10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO

Commission file number: 001-37401

Community Healthcare Trust Incorporated

(Exact Name of Registrant as Specified in Its Charter)

Maryland	46-5212033
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

3326 Aspen Grove Drive

Suite 150

Franklin, Tennessee 37067

(Address of Principal Executive Offices) (Zip Code)

(615) 771-3052

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.01 par value per share	CHCT	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒     No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒     No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated filer ☐ Emerging-growth company ☐ Non-accelerated filer ☐ Smaller reporting  company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes  ☐     No ☒

The Registrant had 25,099,256 shares of Common Stock, $0.01 par value per share, outstanding as of July 27, 2022.

1

COMMUNITY HEALTHCARE TRUST INCORPORATED

FORM 10-Q

June 30, 2022

TABLE OF CONTENTS

		Page
PART I.—FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statements of Stockholders' Equity	6
	Condensed Consolidated Statements of Cash Flows	8
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32
Item 4.	Controls and Procedures	32
PART II.—OTHER INFORMATION		33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3.	Defaults Upon Senior Securities	33
Item 4.	Mine Safety Disclosures	33
Item 5.	Other Information	33
Item 6.	Exhibits	33
SIGNATURES		35

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars and shares in thousands, except per share amounts)

	(Unaudited)
	June 30, 2022		December 31, 2021
ASSETS
Real estate properties
Land and land improvements	$	101,909	$	97,397
Buildings, improvements, and lease intangibles	764,338		736,465
Personal property	234		223
Total real estate properties	866,481		834,085
Less accumulated depreciation	(149,049)		(133,056)
Total real estate properties, net	717,432		701,029
Cash and cash equivalents	1,699		2,351
Restricted cash	659		516
Other assets, net	66,244		50,337
Total assets	$	786,034	$	754,233
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net	$	291,726	$	265,625
Accounts payable and accrued liabilities	7,219		7,845
Other liabilities, net	14,127		18,651
Total liabilities	313,072		292,121
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding	—		—
Common stock, $0.01 par value; 450,000 shares authorized; 25,099 and 24,983 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	251		250
Additional paid-in capital	599,631		595,624
Cumulative net income	70,231		59,123
Accumulated other comprehensive income (loss)	12,761		(4,980)
Cumulative dividends	(209,912)		(187,905)
Total stockholders’ equity	472,962		462,112
Total liabilities and stockholders' equity	$	786,034	$	754,233

See accompanying notes to the condensed consolidated financial statements.

3

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited; Dollars and shares in thousands, except per share amounts)

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
REVENUES
Rental income	$	23,197	$	22,006	$	45,801	$	42,786
Other operating interest	852		682		1,729		1,297
	24,049		22,688		47,530		44,083
EXPENSES
Property operating	4,062		3,843		8,153		7,572
General and administrative	3,610		2,893		6,926		5,752
Depreciation and amortization	8,077		7,539		16,019		14,763
	15,749		14,275		31,098		28,087
INCOME BEFORE INCOME TAXES AND OTHER ITEMS	8,300		8,413		16,432		15,996
Interest expense	(2,755)		(2,736)		(5,381)		(4,966)
Deferred income tax (expense) benefit	(16)		(20)		1		(59)
Interest and other income	55		53		56		54
NET INCOME	$	5,584	$	5,710	$	11,108	$	11,025
NET INCOME PER COMMON SHARE:
Net income per common share – Basic	$	0.21	$	0.22	$	0.41	$	0.43
Net income per common share – Diluted	$	0.21	$	0.22	$	0.41	$	0.43
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC	23,578		23,195		23,574		23,003
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED	23,578		23,195		23,574		23,003

See accompanying notes to the condensed consolidated financial statements.

4

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited; Dollars in thousands)

			Three Months Ended June 30,				Six Months Ended June 30,
			2022		2021		2022		2021
NET INCOME			$	5,584	$	5,710	$	11,108	$	11,025
	Other comprehensive income (loss):
		Increase (decrease) in fair value of cash flow hedges	4,584		(2,788)		15,991		15
		Reclassification for amounts recognized as interest expense	635		1,160		1,750		2,092
	Total other comprehensive income (loss)		5,219		(1,628)		17,741		2,107
COMPREHENSIVE INCOME			$	10,803	$	4,082	$	28,849	$	13,132

See accompanying notes to the condensed consolidated financial statements.

5

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

(Unaudited; Dollars and shares in thousands, except per share amounts)

	Preferred Stock			Common Stock			Additional Paid in Capital		Cumulative Net Income		Accumulated Other Comprehensive Income (Loss)		Cumulative Dividends		Total Stockholders' Equity
	Shares	Amount		Shares	Amount
Balance at March 31, 2022	—	$	—	25,072	$	251	$	597,548	$	64,647	$	7,542	$	(198,874)	$	471,114
Issuance of common stock, net of issuance costs	—	—		—	—		(101)		—		—		—		(101)
Stock-based compensation	—	—		27	—		2,184		—		—		—		2,184
Unrecognized gain on cash flow hedges	—	—		—	—		—		—		4,584		—		4,584
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—		635		—		635
Net income	—	—		—	—		—		5,584		—		—		5,584
Dividends to common stockholders ($0.44 per share)	—	—		—	—		—		—		—		(11,038)		(11,038)
Balance at June 30, 2022	—	$	—	25,099	$	251	$	599,631	$	70,231	$	12,761	$	(209,912)	$	472,962
Balance at December 31, 2021	—	$	—	24,983	$	250	$	595,624	$	59,123	$	(4,980)	$	(187,905)	$	462,112
Issuance of common stock, net of issuance costs	—	—		—	—		(299)		—		—		—		(299)
Stock-based compensation, net of shares withheld and forfeited	—	—		116	1		4,306		—		—		—		4,307
Unrecognized gain on cash flow hedges	—	—		—	—		—		—		15,991		—		15,991
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—		1,750		—		1,750
Net income	—	—		—	—		—		11,108		—		—		11,108
Dividends to common stockholders ($0.8775 per share)	—	—		—	—		—		—		—		(22,007)		(22,007)
Balance at June 30, 2022	—	$	—	25,099	$	251	$	599,631	$	70,231	$	12,761	$	(209,912)	$	472,962

See accompanying notes to the condensed consolidated financial statements.

6

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021

(Unaudited; Dollars and shares in thousands, except per share amounts)

	Preferred Stock			Common Stock			Additional Paid in Capital		Cumulative Net Income		Accumulated Other Comprehensive (Loss) Income		Cumulative Dividends		Total Stockholders' Equity
	Shares	Amount		Shares	Amount
Balance at March 31, 2021	—	$	—	24,417	$	244	$	571,781	$	41,946	$	(8,111)	$	(155,774)	$	450,086
Issuance of common stock, net of issuance costs	—	—		248	2		11,792		—		—		—		11,794
Stock-based compensation	—	—		22	1		1,604		—		—		—		1,605
Unrecognized loss on cash flow hedges	—	—		—	—		—		—		(2,788)		—		(2,788)
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—		1,160		—		1,160
Net income	—	—		—	—		—		5,710		—		—		5,710
Dividends to common stockholders ($0.43 per share)	—	—		—	—		—		—		—		(10,511)		(10,511)
Balance at June 30, 2021	—	$	—	24,687	$	247	$	585,177	$	47,656	$	(9,739)	$	(166,285)	$	457,056
Balance at December 31, 2020	—	$	—	23,888	$	239	$	550,391	$	36,631	$	(11,846)	$	(145,499)	$	429,916
Issuance of common stock, net of issuance costs	—	—		683	7		31,632		—		—		—		31,639
Stock-based compensation	—	—		116	1		3,154		—		—		—		3,155
Unrecognized gain on cash flow hedges	—	—		—	—		—		—		15		—		15
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—		2,092		—		2,092
Net income	—	—		—	—		—		11,025		—		—		11,025
Dividends to common stockholders ($0.8575 per share)	—	—		—	—		—		—		—		(20,786)		(20,786)
Balance at June 30, 2021	—	$	—	24,687	$	247	$	585,177	$	47,656	$	(9,739)	$	(166,285)	$	457,056

See accompanying notes to the condensed consolidated financial statements.

7

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

	Six Months Ended June 30,
	2022		2021
OPERATING ACTIVITIES
Net income	$	11,108	$	11,025
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	16,019		14,763
Other amortization	419		415
Stock-based compensation	4,307		3,155
Straight-line rent receivable	(1,737)		(1,818)
Deferred income tax (benefit) expense	(1)		59
Changes in operating assets and liabilities:
Other assets	(782)		(393)
Accounts payable and accrued liabilities	263		(108)
Other liabilities	(77)		1,004
Net cash provided by operating activities	29,519		28,102
INVESTING ACTIVITIES
Acquisitions of real estate	(28,671)		(68,921)
Acquisition and funding of notes receivable	(3,000)		(11,520)
Proceeds from the repayment of notes receivable	1,500		1,592
Capital expenditures on existing real estate properties	(3,648)		(3,065)
Net cash used in investing activities	(33,819)		(81,914)
FINANCING ACTIVITIES
Net borrowings (repayments) on revolving credit facility	26,000		(28,000)
Term loan borrowings	—		125,000
Term loan repayments	—		(50,000)
Mortgage note repayments	(69)		(57)
Dividends paid	(22,007)		(20,786)
Proceeds from issuance of common stock	—		31,793
Equity issuance costs	(133)		(130)
Debt issuance costs	—		(1,646)
Net cash provided by financing activities	3,791		56,174
(Decrease) increase in cash and cash equivalents and restricted cash	(509)		2,362
Cash and cash equivalents and restricted cash, beginning of period	2,867		2,892
Cash and cash equivalents and restricted cash, end of period	$	2,358	$	5,254
Supplemental Cash Flow Information:
Interest paid (net of capitalized interest)	$	5,053	$	4,599
Invoices accrued for construction, tenant improvement and other capitalized costs	$	1,395	$	1,240
Reclassification of registration statement costs incurred in prior year to equity issuance costs	$	221	$	163
Increase in fair value of cash flow hedges	$	15,991	$	15
Income taxes paid	$	42	$	25
Capitalized interest	$	364	$	73

See accompanying notes to the condensed consolidated financial statements.

8

COMMUNITY HEALTHCARE TRUST INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2022

(Unaudited)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. As of June 30, 2022, the Company had investments of approximately $869.5 million in 159 real estate properties (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million). The properties are located in 34 states, totaling approximately 3.4 million square feet in the aggregate and were approximately 90.3% leased at June 30, 2022 with a weighted average remaining lease term of approximately 7.8 years. Any references to square footage, property count, or occupancy percentages, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm's review.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2022. All intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Cash and Cash Equivalents and Restricted Cash

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amounts approximate fair value due to the short term maturity of these investments. The following table provides a reconciliation of cash and cash equivalents and restricted cash:

	Balance as of June 30,
(Dollars in thousands)	2022		2021
Cash and cash equivalents	$	1,699	$	4,787
Restricted cash	659		467
Cash, cash equivalents and restricted cash	$	2,358	$	5,254

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and two subsidiaries have also elected for those subsidiaries to be treated as taxable REIT subsidiaries ("TRSs"), which are subject to federal and state income taxes.

9

Notes to Condensed Consolidated Financial Statements - Continued

No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRSs to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT.

New Accounting Pronouncements

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848). ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. During the first quarter of 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

NOTE 2. REAL ESTATE PROPERTIES

As of June 30, 2022, we had investments of approximately $869.5 million in 159 real estate properties (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million). The Company's investments are diversified by property type, geographic location, and tenant as shown in the following tables:

Property Type	# of Properties	Gross Investment (in thousands)
Medical Office Building	65	$	298,680
Acute Inpatient Behavioral	5	130,410
Inpatient Rehabilitation Facilities	7	151,234
Specialty Centers	34	106,193
Physician Clinics	29	82,213
Surgical Centers and Hospitals	10	54,851
Behavioral Specialty Facilities	8	30,978
Long-term Acute Care Hospitals	1	14,937
Total	159	$	869,496

State	# of Properties	Gross Investment (in thousands)
Texas	15	$	137,523
Illinois	16	120,339
Ohio	23	101,144
Florida	14	66,265
Massachusetts	2	35,298
All Others	89	408,927
Total	159	$	869,496

10

Notes to Condensed Consolidated Financial Statements - Continued

Primary Tenant	# of Properties	Gross Investment (in thousands)
Everest Rehabilitation	4	$	80,658
US Healthvest	3	77,964
All Others	152	710,874
Total	159	$	869,496

NOTE 3. REAL ESTATE LEASES

Lessor Accounting

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2039. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and may also include additional rent, which may include the reimbursement of taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property.

Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease.

Future minimum lease payments under the non-cancelable operating leases due to the Company for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ending December 31)	$	39,823
2023	76,469
2024	71,470
2025	66,222
2026	59,091
2027 and thereafter	375,290
	$	688,365

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis when collection of rental payments over the term of the lease is probable. Straight-line rent included in rental income was approximately $0.9 million and $1.0 million, respectively, for the three months ended June 30, 2022 and 2021, and was approximately $1.7 million and $1.8 million, respectively, for the six months ended June 30, 2022 and 2021.

Purchase Option Provisions

Certain of the Company's leases provide the lessee with a purchase option or a right of first refusal to purchase the leased property. The purchase option provisions generally allow the lessee to purchase the leased property at fair value or at an amount greater than the Company's gross investment in the leased property at the time of the purchase.

At June 30, 2022, the Company had an aggregate gross investment of approximately $28.1 million in five real estate properties with purchase options exercisable at June 30, 2022 that had not been exercised.

11

Notes to Condensed Consolidated Financial Statements - Continued

Sales-type Lease

The Company has a portion of one property accounted for as a sales-type lease with a gross amount totaling approximately $3.0 million included in other assets, net on the Company's Condensed Consolidated Balance Sheets. Future lease payments due to the Company under this lease for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ended December 31)	$	165
2023	336
2024	346
2025	356
2026	367
2027 and thereafter	5,587
Total undiscounted lease receivable	7,157
Discount	(4,124)
Lease receivable	$	3,033

The Company recognized interest income of approximately $0.1 million and $0.1 million, respectively, during the three months ended June 30, 2022 and 2021 and recognized approximately $0.2 million and $0.2 million, respectively, of interest income during the six months ended June 30, 2022 and 2021 related to this lease which is included in other operating interest on the Company's Consolidated Income Statements.

Lessee Accounting

At June 30, 2022, the Company was obligated, as the lessee, under four non-prepaid ground leases accounted for as operating leases with expiration dates, including renewal options, through 2076, and one non-prepaid ground lease accounted for as a financing lease with an expiration date through 2085, including renewal options. Any rental increases related to the Company's ground leases are generally either stated or based on the Consumer Price Index. The Company's future lease payments under these non-prepaid ground leases were as follows (in thousands):

	Operating		Financing
2022 (six months ended December 31)	$	21	$	63
2023	42		125
2024	43		138
2025	44		138
2026	44		138
2027 and thereafter	1,193		5,483
Total undiscounted lease payments	1,387		6,085
Discount	(596)		(3,114)
Lease liabilities	$	791	$	2,971

12

Notes to Condensed Consolidated Financial Statements - Continued

The following table discloses other information regarding the ground leases.

	June 30,
	2022		2021
Operating leases:
Weighted-average remaining lease term in years (including renewal options)	36.43		37.63
Weighted-average discount rate	4.0	%	4.0	%
Financing leases:
Weighted-average remaining lease term in years (including renewal options)	36.5		35.5
Weighted-average discount rate	4.1	%	4.1	%

NOTE 4. REAL ESTATE ACQUISITIONS

During the second quarter of 2022, the Company acquired one real estate property. Upon acquisition, the property was 100% leased with a lease expiration in 2037. Amounts reflected in revenues and net income for this property for the three months ended June 30, 2022 were approximately $0.4 million and $0.3 million, respectively, and transaction costs totaling approximately $0.1 million were capitalized relating to the property acquisition.

During the first quarter of 2022, the Company acquired two real estate properties. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations through 2028. Amounts reflected in revenues and net income for these properties for the six months ended June 30, 2022 were approximately $0.3 million and $43,000, respectively, and transaction costs totaling approximately $0.1 million were capitalized relating to these property acquisitions.

Location	Property Type (1)	Date Acquired	Purchase Price		Cash Consideration		Real Estate		Other		Square Footage
			(000's)		(000's)		(000's)		(000's)
Toledo, OH	MOB	03/09/22	$	2,606	$	2,621	$	2,735	$	(114)	17,465
Fremont, NE	MOB	03/09/22	3,232		3,224		3,443		(219)		12,850
Cincinnati, OH	IRF	05/12/22	23,500		22,826		23,558		(732)		37,720
			$	29,338	$	28,671	$	29,736	$	(1,065)	68,035
(1) MOB - Medical Office Building; IRF - Inpatient Rehabilitation Facility

13

Notes to Condensed Consolidated Financial Statements - Continued

The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the six months ended June 30, 2022.

			Relative Fair Value		Estimated Useful Life
			(in thousands)		(in years)
Land and land improvements			$	4,258	12.7
Building and building improvements			24,290		45.3
Intangibles:
	At-market lease intangibles		1,187		4.5
	Below-market lease intangibles		(194)		6.1
		Total intangibles	993
Accounts payable, accrued liabilities and other liabilities assumed			(97)
Prorated rent, interest and operating expense reimbursement amounts collected			(773)
	Total cash consideration		$	28,671

NOTE 5. DEBT, NET

The table below details the Company's debt as of June 30, 2022 and December 31, 2021.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021		Maturity Dates
Credit Facility:
Revolving Credit Facility	$	38,000	$	12,000	3/26
A-2 Term Loan, net	49,855		49,813		3/24
A-3 Term Loan, net	74,548		74,487		3/26
A-4 Term Loan, net	124,352		124,296		3/28
Mortgage Note Payable, net	4,971		5,029		5/24
	$	291,726	$	265,625

On March 19, 2021, Community Healthcare Trust Incorporated, as borrower, entered into a third amended and restated credit facility by and among Community Healthcare Trust Incorporated, as borrower, the several banks and financial institutions party thereto as lenders, and Truist Bank, as administrative agent (the "Credit Facility").

The Credit Facility allows the Company to borrow, through the accordion feature, up to $600.0 million, including the ability to add and fund incremental term loans, and provides the Company the ability to apply lower margins to its annual interest rate after it obtains an investment grade rating of BBB-/Baa3 (or the equivalent) from a rating agency, and modified its debt covenants.

The Credit Facility provides for a $150.0 million Revolving Credit Facility and $250.0 million in term loans (the "Term Loans"). The Revolving Credit Facility matures on March 19, 2026 and includes one 12-month option to extend the maturity date, subject to the satisfaction of certain conditions. The Term Loans include a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "A-2 Term Loan"), which matures on March 29, 2024, a seven-year term loan facility in the aggregate principal amount of $75.0 million (the "A-3 Term Loan"), which matures on March 29, 2026, and a seven-year term loan facility in the aggregate principal amount of $125.0 million (the "A-4 Term Loan), which matures on March 19, 2028.

14

Notes to Condensed Consolidated Financial Statements - Continued

Amounts outstanding under the Revolving Credit Facility bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 1.90% or (ii) a base rate plus 0.25% to 0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.20% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.25% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. The Company had $38.0 million outstanding under the Revolving Credit Facility with a weighted average interest rate of 2.9% and a borrowing capacity remaining of $112.0 million at June 30, 2022.

Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.45% to 2.30% or (ii) a base rate plus 0.45% to 1.30%, in each case, depending upon the Company’s leverage ratio. The Company has entered into interest rate swaps to fix the interest rates on the Term Loans. See Note 6 – Derivative Financial Instruments for more details on the interest rate swaps. At June 30, 2022, the Company had $250.0 million outstanding under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 3.79%.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. The Company was in compliance with its financial covenants under its Credit Facility as of June 30, 2022.

NOTE 6. DERIVATIVE FINANCIAL INSTRUMENTS

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

As of June 30, 2022, the Company had twelve outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $250.0 million.

15

Notes to Condensed Consolidated Financial Statements - Continued

Tabular Disclosure of Fair Value of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
(Dollars in thousands)	June 30, 2022		December 31, 2021		Balance Sheet Classification	June 30, 2022		December 31, 2021		Balance Sheet Classification
Interest rate swaps	$	12,761	$	343	Other assets, net	$	—	$	5,324	Other liabilities, net

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) ("AOCI") and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $3.3 million will be reclassified from AOCI as a decrease to interest expense.

Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2022 and 2021.

	Three Months Ended June 30,				Six Months Ended June 30,
(Dollars in thousands)	2022		2021		2022		2021
Amount of unrealized gain (loss) recognized in OCI on derivatives	$	4,584	$	(2,788)	$	15,991	$	15
Amount of loss reclassified from AOCI into interest expense	$	635	$	1,160	$	1,750	$	2,092
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	2,755	$	2,736	$	5,381	$	4,966

Tabular Disclosures of Offsetting Derivatives

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of June 30, 2022 and December 31, 2021. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Condensed Consolidated Balance Sheets.

Offsetting of Derivative Assets (as of June 30, 2022)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	12,761	$	—	$	12,761	$	—	$	—	$	12,761

16

Notes to Condensed Consolidated Financial Statements - Continued

Offsetting of Derivative Liabilities (as of June 30, 2022)

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets

(In thousands)

Gross Amounts of Recognized Liabilities

Gross Amounts Offset in the Condensed Consolidated Balance Sheet

Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets

Financial Instruments

Cash Collateral Received

Net Amount

Derivatives

$

—

$

—

$

—

$

—

$

—

$

—

Offsetting of Derivative Assets (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	343	$	—	$	343	$	(247)	$	—	$	96

Offsetting of Derivative Liabilities (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	(5,324)	$	—	$	(5,324)	$	247	$	—	$	(5,077)

Credit-risk-related Contingent Features

As of June 30, 2022, the Company did not have any derivatives in a net liability position. As of June 30, 2022, the Company had not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company terminated these interest rate swaps or breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value.

NOTE 7. STOCKHOLDERS' EQUITY

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2022 and for the year ended December 31, 2021:

(In thousands)	Six Months Ended June 30, 2022	Year Ended December 31, 2021
Balance, beginning of period	24,983	23,888
Issuance of common stock	—	823
Restricted stock issued	119	273
Restricted stock withheld and forfeited	(3)	(1)
Balance, end of period	25,099	24,983

ATM Program

The Company has an at-the-market offering program ("ATM Program"), with Piper Sandler & Co., Evercore Group L.L.C., Truist Securities, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC., as sales agents (collectively, the “Agents”). Under the ATM Program, the

17

Notes to Condensed Consolidated Financial Statements - Continued

Company may issue and sell shares of its common stock, having an aggregate gross sales price of up to $360.0 million. The shares of common stock may be sold from time to time through or to one or more of the Agents, as may be determined by the Company in its sole discretion, subject to the terms and conditions of the agreement and applicable law.

The Company elected not to issue any shares under the ATM Program during the six months ended June 30, 2022. As of June 30, 2022, the Company had approximately $101.0 million remaining that may be issued under the ATM Program.

NOTE 8. NET INCOME PER COMMON SHARE

The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2022 and 2021, respectively.

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except per share data)	2022		2021		2022		2021
Net income	$	5,584	$	5,710	$	11,108	$	11,025
Participating securities' share in earnings	(668)		(547)		(1,327)		(1,085)
Net income, less participating securities' share in earnings	$	4,916	$	5,163	$	9,781	$	9,940
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	25,087		24,457		25,074		24,256
Unvested restricted shares	(1,509)		(1,262)		(1,500)		(1,253)
Weighted average Common Shares outstanding–Basic	23,578		23,195		23,574		23,003
Dilutive potential common shares	—		—		—		—
Weighted average Common Shares outstanding –Diluted	23,578		23,195		23,574		23,003
Basic Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43
Diluted Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43

NOTE 9. STOCK INCENTIVE PLAN

A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three and six months ended June 30, 2022 and 2021 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods.

		Three Months Ended June 30,				Six Months Ended June 30,
(Dollars and shares in thousands)		2022		2021		2022		2021
Stock-based awards, beginning of period		1,502		1,258		1,416		1,165
	Stock in lieu of compensation	8		6		52		50
	Stock awards	19		16		67		65
	Total stock granted	27		22		119		115
	Vested shares	(17)		(20)		(22)		(20)
	Forfeited shares	—		—		(1)		—
Stock-based awards, end of period		1,512		1,260		1,512		1,260
Amortization expense		$	2,184	$	1,606	$	4,307	$	3,164

18

Notes to Condensed Consolidated Financial Statements - Continued

NOTE 10. OTHER ASSETS, NET

Other assets, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Notes receivable	$	27,500	$	26,000
Accounts and interest receivable	2,463		2,116
Straight-line rent receivable	13,723		11,968
Prepaid assets	728		701
Deferred financing costs, net	790		896
Leasing commissions, net	1,389		1,239
Deferred tax assets, net	349		348
Fair value of interest rate swaps	12,761		343
Above-market lease intangible assets, net	517		611
Sales-type lease receivable	3,033		3,031
Financing right-of-use asset	1,844		1,870
Operating lease right-of-use assets	774		788
Other	373		426
	$	66,244	$	50,337

The Company's notes receivable mainly included:

•At June 30, 2022 and December 31, 2021, notes receivable included a $10.5 million and $12.0 million, respectively, term loan, secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital owned by the borrower. The term loan will be repaid in equal monthly installments of $250,000 through the maturity date of December 31, 2025 and bears interest at 9% per annum.

•At June 30, 2022 and December 31, 2021, notes receivable included a $6.0 million and $6.0 million, respectively, term loan and a $11.0 million and $8.0 million, respectively, revolving credit facility, secured by assets and ownership interests of six geriatric behavioral hospitals and affiliated companies all of which are co-borrowers on the loans. The term loan bears interest at 9% per annum, with interest only payments due initially and then equal monthly installments of principal payments due beginning June 30, 2023. The term loan facility matures on July 1, 2027. The revolving credit facility bears interest at 9% per annum and matures on December 31, 2025. In addition, the Company has committed to fund, at the Company’s discretion, additional amounts, up to $5.0 million with interest at 9% per annum on any amount funded, that may be used by the borrower to pay existing liabilities of co-borrowers. The term loan, the revolving credit facility and the additional commitment all include a 3% non-cash interest charge that is due and payable upon the earlier of the repayment or maturity of each note.

19

Notes to Condensed Consolidated Financial Statements - Continued

The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material decision-making rights or control of the entities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at June 30, 2022 are summarized in the table below.

Classification	Carrying Amount (in thousands)		Maximum Exposure to Loss (in thousands)
Note receivable (term loan)	$	10,500	$	10,500
Note receivable (revolving credit facility)	$	11,000	$	11,000
Note receivable (term loan)	$	6,000	$	6,000

NOTE 11. OTHER LIABILITIES, NET

Other liabilities, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Prepaid rent	$	3,967	$	3,791
Security deposits	5,224		4,640
Below-market lease intangibles, net	720		616
Fair value of derivatives	—		5,324
Financing lease liability	2,971		2,973
Operating lease liability	791		795
Other	454		512
	$	14,127	$	18,651

NOTE 12. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy.

20

Notes to Condensed Consolidated Financial Statements - Continued

Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy.

The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at June 30, 2022 and December 31, 2021, using level 2 inputs.

	June 30, 2022				December 31, 2021
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Notes receivable	$	27,500	$	26,641	$	26,000	$	25,869
Interest rate swap asset	$	12,761	$	12,761	$	343	$	343
Interest rate swap liability	$	—	$	—	$	5,324	$	5,324
Mortgage note payable (principal amount)	$	5,007	$	4,886	$	5,076	$	5,129

NOTE 13. SUBSEQUENT EVENTS

Dividend Declared

On July 28, 2022, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.4425 per share. The dividend is payable on August 26, 2022 to stockholders of record on August 12, 2022.

Restricted Stock Issuances

On July 29, 2022, the Company issued 72,431 shares of restricted stock to its executive officers under the Company's 2014 Incentive Plan with an 8-year vesting period.

21

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Disclosure Regarding Forward-Looking Statements

This report and other materials that Community Healthcare Trust Incorporated (the "Company") has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, effects on global and national markets as well as businesses resulting from the COVID-19 pandemic, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this report and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of the Company's consolidated financial condition, results of operations and cash. MD&A is provided as a supplement to, and should be read in conjunction with, the Company's Condensed Consolidated Financial Statements and accompanying notes.

Overview

References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated subsidiaries.

We were organized in the State of Maryland on March 28, 2014. We are a self-administered, self-managed healthcare real estate investment trust, or REIT, that acquires and owns properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers.

Trends and Matters Impacting Operating Results

Management monitors factors and trends that it believes are important to the Company and the REIT industry in order to gauge their potential impact on the operations of the Company. Certain of the factors and trends that management believes may impact the operations of the Company are discussed below.

22

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

Real Estate Acquisitions

During the first six months of 2022, the Company acquired three real estate properties totaling approximately 68,035 square feet for an aggregate purchase price of approximately $29.3 million and cash consideration of approximately $28.7 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations through 2037. These acquisitions were funded with cash on hand and proceeds from the Company's Revolving Credit Facility. See Note 4 – Real Estate Acquisitions to the Condensed Consolidated Financial Statements for more details on these acquisitions.

Acquisition Pipeline

The Company has three properties under definitive purchase agreements for an aggregate expected purchase price of approximately $23.4 million. The Company's expected returns on these investments range from 9.0% to 9.72%. The Company expects to close on these properties in the second half of 2022; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close. The Company expects to fund these acquisitions with cash on hand, proceeds from the Company's ATM Program, or proceeds from the Company's Revolving Credit Facility.

The Company also has five properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $117.5 million. The Company's expected return on these investments will approximate 10.25%. The Company anticipates closing on these properties from the fourth quarter of 2022 through the fourth quarter of 2023; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

Leased Square Footage

As of June 30, 2022, our real estate portfolio was approximately 90.3% leased. During the first six months of 2022, we had expiring or terminated leases related to approximately 239,000 square feet, and we leased or renewed leases relating to approximately 247,000 square feet.

Purchase Option Provisions

Certain of the Company's leases provide the lessee with a purchase option or a right of first refusal to purchase the leased property. The purchase option provisions generally allow the lessee to purchase the leased property at fair value or at an amount greater than the Company's gross investment in the leased property at the time of the purchase.

At June 30, 2022, the Company had an aggregate gross investment of approximately $28.1 million in five real estate properties with purchase options exercisable at June 30, 2022 that had not been exercised.

Seasonality

We do not expect our business to be subject to material seasonal fluctuations.

New Accounting Pronouncements

See Note 1 – Summary of Significant Accounting Policies to the Company’s Condensed Consolidated Financial Statements accompanying this report for information on new accounting standards recently adopted and not yet adopted.

23

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

Results of Operations

The Company's results of operations for the three and six months ended June 30, 2022 compared to the same periods in 2021 were impacted by real estate acquisitions, capital market activity, the amortization of non-cash compensation, as well as other items discussed in more detail below.

Three Months Ended June 30, 2022 Compared to Three Months Ended June 30, 2021

The table below shows our results of operations for the three months ended June 30, 2022 compared to the same period in 2021 and the effect of changes in those results from period to period on our net income.

	Three Months Ended June 30,				Increase (Decrease) to Net income
(Dollars in thousands)	2022		2021		$		%
REVENUES
Rental income	$	23,197	$	22,006	$	1,191	5.4	%
Other operating interest	852		682		170		24.9	%
	24,049		22,688		1,361		6.0	%
EXPENSES
Property operating	4,062		3,843		(219)		(5.7)	%
General and administrative	3,610		2,893		(717)		(24.8)	%
Depreciation and amortization	8,077		7,539		(538)		(7.1)	%
	15,749		14,275		(1,474)		(10.3)	%
INCOME BEFORE INCOME TAXES AND OTHER ITEMS	8,300		8,413		(113)		(1.3)	%
Interest expense	(2,755)		(2,736)		(19)		(0.7)	%
Deferred income tax expense	(16)		(20)		4		20.0	%
Interest and other income	55		53		2		3.8	%
NET INCOME	$	5,584	$	5,710	$	(126)	(2.2)	%

Revenues

Rental income increased approximately $1.2 million, or 5.4%, for the three months ended June 30, 2022 compared to the same period in 2021 due mainly to acquisitions of real estate in 2022 and 2021.

Other operating interest increased $0.2 million, or 24.9%, for the three months ended June 30, 2022 compared to the same period in 2021. This increase in interest was due to additional amounts funded under existing notes receivable.

Expenses

Property operating expenses increased approximately $0.2 million, or 5.7%, for the three months ended June 30, 2022 compared to the same period in 2021 mainly due to acquisitions of real estate in 2022 and 2021.

General and administrative expenses increased approximately $0.7 million, or 24.8%, for the three months ended June 30, 2022 compared to the same period in 2021 due mainly to the non-cash amortization of non-vested restricted common shares granted in 2022 and 2021.

Depreciation and amortization expense increased approximately $0.5 million, or 7.1%, for the three months ended June 30, 2022 compared to the same period in 2021. This increase was comprised mainly of the following:

•Acquisitions of real estate in 2022 and 2021 resulted in an increase of approximately $0.7 million;

24

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

•Tenant improvements and other capital expenditures resulted in an increase of approximately $0.2 million; and

•Fully amortized real estate lease intangibles which generally have a shorter depreciable life than a building resulted in a decrease of approximately $0.4 million.

Six Months Ended June 30, 2022 Compared to Six Months Ended June 30, 2021

The table below shows our results of operations for the six months ended June 30, 2022 compared to the same period in 2021 and the effect of changes in those results from period to period on our net income.

	Six Months Ended June 30,				Increase (Decrease) to Net income
(Dollars in thousands)	2022		2021		$		%
REVENUES
Rental income	$	45,801	$	42,786	$	3,015	7.0	%
Other operating interest	1,729		1,297		432		33.3	%
	47,530		44,083		3,447		7.8	%
EXPENSES
Property operating	8,153		7,572		(581)		(7.7)	%
General and administrative	6,926		5,752		(1,174)		(20.4)	%
Depreciation and amortization	16,019		14,763		(1,256)		(8.5)	%
	31,098		28,087		(3,011)		(10.7)	%
INCOME BEFORE INCOME TAXES AND OTHER ITEMS	16,432		15,996		436		2.7	%
Interest expense	(5,381)		(4,966)		(415)		(8.4)	%
Deferred income tax benefit (expense)	1		(59)		60		101.7	%
Interest and other income	56		54		2		3.7	%
NET INCOME	$	11,108	$	11,025	$	83	0.8	%

Revenues

Revenues increased approximately $3.0 million, or 7.0%, for the six months ended June 30, 2022 compared to the same period in 2021 due mainly to acquisitions of real estate in 2022 and 2021.

Other operating interest increased $0.4 million, or 33.3%, for the six months ended June 30, 2022 compared to the same period in 2021. This increase in interest was due to additional amounts funded under existing notes receivable.

Expenses

Property operating expenses increased approximately $0.6 million, or 7.7%, for the six months ended June 30, 2022 compared to the same period in 2021. This increase was due mainly to:

•Acquisitions of real estate in 2022 and 2021 contributed to an increase of approximately $0.7 million; offset partially by

•Operating expenses on the existing portfolio decreasing by approximately $0.1 million.

General and administrative expenses increased approximately $1.2 million, or 20.4%, for the six months ended June 30, 2022 compared to the same period in 2021 due mainly to the non-cash amortization of non-vested restricted common shares granted in 2022 and 2021.

25

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

Depreciation and amortization expense increased approximately $1.3 million, or 8.5%, for the six months ended June 30, 2022 compared to the same period in 2021. The increase was comprised mainly of the following:

•Acquisitions of real estate in 2022 and 2021 resulted in an increase of approximately $1.6 million;

•Tenant improvements and other capital expenditures resulted in an increase of approximately $0.4 million; and

•Fully amortized real estate lease intangibles which generally have a shorter depreciable life than a building resulted in a decrease of approximately $0.7 million.

Interest expense

Interest expense increased approximately $0.4 million, or 8.4%, for the six months ended June 30, 2022 compared to the same period in 2021. This increase relates mainly to:

•The Company's Credit Facility, refinanced in March 2021, resulted in an increase of approximately $0.7 million; and

•Interest capitalized on construction projects resulted in a decrease of approximately $0.3 million.

Non-GAAP Financial Measures and Key Performance Indicators

Management considers certain non-GAAP financial measures and key performance indicators to be useful supplemental measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. The Company reports non-GAAP financial measures because these measures are observed by management to also be among the most predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these non-GAAP financial measures. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors, as well as reconciliations of those measures to the most directly comparable GAAP financial measure.

The non-GAAP financial measures and key performance indicators presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Condensed Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.

Funds from Operations ("FFO") and Adjusted Funds from Operations ("AFFO")

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income (calculated in accordance with GAAP), excluding gains or losses from the sale of certain real estate assets, gains and losses from change in control, impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures. NAREIT also provides REITs with an option to exclude gains, losses and impairments of assets that are incidental to the main business of the REIT from the calculation of FFO.

In addition to FFO, the Company presents AFFO and AFFO per share. The Company defines AFFO as FFO, excluding certain expenses related to closing costs of properties acquired accounted for as business combinations

26

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

and mortgages funded, excluding straight-line rent and the amortization of stock-based compensation, and including or excluding other non-cash items from time to time. AFFO presented herein may not be comparable to similar measures presented by other real estate companies due to the fact that not all real estate companies use the same definition.

Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO, AFFO, FFO per share and AFFO per share provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, impairments and gains or losses from sales of real estate, losses and impairment of incidental assets, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO, AFFO, FFO per share and AFFO per share can facilitate comparisons of operating performance between periods.

The table below reconciles net income to FFO and AFFO for the three months ended June 30, 2022 compared to the same period in 2021.

	Three Months Ended June 30,
(In thousands, except per share amounts)	2022		2021
Net income	$	5,584	$	5,710
Real estate depreciation and amortization	8,141		7,593
FFO	$	13,725	$	13,303
Straight-line rent	(917)		(981)
Stock-based compensation	2,184		1,606
AFFO	$	14,992	$	13,928
FFO per diluted common share	$	0.57	$	0.56
AFFO per diluted common share	$	0.62	$	0.58
Weighted average common shares outstanding - diluted (1)	24,247		23,908

___________________

(1) Diluted weighted average common shares outstanding for FFO and AFFO are calculated based on the treasury method, rather than the 2-class method used to calculate earnings per share.

Net Operating Income ("NOI")

NOI is a key performance indicator. NOI is defined as net income or loss, computed in accordance with GAAP, generated from our total portfolio of properties and other investments before general and administrative expenses, depreciation and amortization expense, gains or loss on the sale of real estate properties or other investments, interest expense, and income tax expense. We believe that NOI provides an accurate measure of operating performance of our operating assets because NOI excludes certain items that are not associated with management of the properties. The Company's use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing NOI.

27

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

The table below reconciles net income to NOI for the three months ended June 30, 2022 compared to the same period in 2021.

		Three Months Ended June 30,
(In thousands)		2022		2021
Net income		$	5,584	$	5,710
	General and administrative	3,610		2,893
	Depreciation and amortization	8,077		7,539
	Interest expense	2,755		2,736
	Deferred income expense	16		20
	Interest and other income	(55)		(53)
NOI		$	19,987	$	18,845

EBITDAre and Adjusted EBITDAre

The Company uses the NAREIT definition of EBITDAre which is net income plus interest expense, income tax expense, and depreciation and amortization, plus losses or minus gains on the disposition of depreciable property, including losses/gains on change of control, plus impairment write-downs of depreciable property and of investments in unconsolidated affiliates caused by a decrease in value of depreciable property in the affiliate, plus or minus adjustments to reflect the entity's share of EBITDAre of unconsolidated affiliates and consolidated affiliates with non-controlling interest. The Company also presents Adjusted EBITDAre which is EBITDAre before non-cash stock-based compensation expense.

We consider EBITDAre and Adjusted EBITDAre important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

The table below reconciles net income to EBITDAre and Adjusted EBITDAre for the three months ended June 30, 2022 compared to the same period in 2021.

		Three Months Ended June 30,
(In thousands)		2022		2021
Net income		$	5,584	$	5,710
	Interest expense	2,755		2,736
	Depreciation and amortization	8,077		7,539
	Deferred income tax expense	16		20
EBITDAre		$	16,432	$	16,005
	Non-cash stock-based compensation expense	2,184		1,606
Adjusted EBITDAre		$	18,616	$	17,611

Liquidity and Capital Resources

The Company monitors its liquidity and capital resources and relies on several key indicators in its assessment of capital markets for financing acquisitions and other operating activities as needed, including the following:

•Leverage ratios and financial covenants included in our Credit Facility;

•Dividend payout percentage; and

28

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

•Interest rates, underlying treasury rates, debt market spreads and equity markets.

The Company uses these indicators and others to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention.

Sources and Uses of Cash

The Company derives most of its revenues from its real estate properties. Our rental income represents our primary source of liquidity to fund our dividends, general and administrative expenses, property operating expenses, interest expense on our Credit Facility, and other expenses incurred related to managing our existing portfolio. To the extent additional resources are needed, the Company will fund its investment activity generally through equity or debt issuances either in the public or private markets or through proceeds from our Credit Facility.

The Company expects to meet its liquidity needs through cash on hand, cash flows from operations and cash flows from sources discussed above. The Company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs.

Credit Facility

The Company's third amended and restated credit facility (the "Credit Facility") provides for a $150.0 million Revolving Credit Facility that matures on March 19, 2026 and includes one 12-month option to extend the maturity date, and $250.0 million in Term Loans, as well as an accordion feature which allows borrowings up to a total of $600.0 million, including the ability to add and fund additional term loans. Note 5 – Debt, net to the Condensed Consolidated Financial Statements provides more details on the Company's Credit Facility. At June 30, 2022, the Company had borrowing capacity remaining under the Revolving Credit Facility of approximately $112.0 million.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s current financing policy prohibits aggregate debt (secured or unsecured) in excess of 40% of the Company's total capitalization, except for short-term, transitory periods. At June 30, 2022, our debt to total capitalization ratio (debt plus stockholders' equity plus accumulated depreciation) was approximately 31.9%. The Company was in compliance with its financial covenants under its Credit Facility as of June 30, 2022.

Mortgage Note Payable

The Company also had outstanding at June 30, 2022, a $5.0 million mortgage note payable, secured by one of its properties. The mortgage note amortizes monthly at a fixed interest rate of 4.98% with a balloon payment due upon maturity on May 1, 2024.

Acquisition Pipeline

The Company has three properties under definitive purchase agreements for an aggregate expected purchase price of approximately $23.4 million. The Company's expected returns on these investments range from 9.0% to 9.72%. The Company expects to close on these properties in the second half of 2022; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close. The Company expects to fund these acquisitions with cash on hand, proceeds from the Company's ATM Program, or proceeds from the Company's Revolving Credit Facility.

29

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

The Company also has five properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $117.5 million. The Company's expected return on these investments will approximate 10.25%. The Company anticipates closing on these properties from the fourth quarter of 2022 through the fourth quarter of 2023; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

Other Contractual Obligations

Subject to Company approval, we may fund or reimburse tenants for tenant improvements, which are allowed for in certain leases, of up to approximately $9.4 million as of June 30, 2022.

The Company has also entered into contracts regarding certain capital expenditures with remaining commitments totaling approximately $4.3 million as of June 30, 2022. Reimbursement of these expenditures by our tenants will be determined by each tenant's lease.

The Company has ground lease obligations relating to five properties, with total obligations of approximately $7.5 million with maturities through 2085, including renewals.

The Company expects to fund these obligations with cash on hand, proceeds from the Company's ATM Program, proceeds from the Company's Revolving Credit Facility, or other debt or equity offerings.

Automatic Shelf Registration Statement

On November 5, 2019, the Company filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission. The registration statement is for an indeterminate number of securities and is effective for three years. Under this registration statement, the Company has the capacity to offer and sell from time to time various types of securities, including common stock, preferred stock, depository shares, rights, debt securities, warrants and units.

Operating Activities

Cash flows provided by operating activities for the six months ended June 30, 2022 and 2021 were approximately $29.5 million and $28.1 million, respectively. Cash flows provided by operating activities were generally provided by contractual rents and interest on our notes receivable, net of property operating expenses not reimbursed by the tenants and general and administrative expenses.

Investing Activities

Cash flows used in investing activities for the six months ended June 30, 2022 and 2021 were approximately $33.8 million and $81.9 million, respectively. During the six months ended June 30, 2022, the Company invested in three properties for an aggregate cash consideration of approximately $28.7 million and funded notes totaling approximately $3.0 million. Also, during the six months ended June 30, 2022, the Company received payments on its notes totaling $1.5 million and funded capital expenditures on its existing portfolio totaling approximately $3.6 million.

During the six months ended June 30, 2021, the Company invested in 8 properties for an aggregate cash consideration of approximately $68.9 million and funded notes receivable totaling approximately $11.5 million. Also, during the six months ended June 30, 2021, the Company received payments on its notes receivable totaling $1.6 million and funded capital expenditures on its existing portfolio totaling approximately $3.1 million.

Financing Activities

Cash flows provide by financing activities for the six months ended June 30, 2022 and 2021 were approximately $3.8 million and $56.2 million, respectively. During the six months ended June 30, 2022, the Company borrowed $26.0 million under its Revolving Credit Facility and paid dividends totaling approximately $22.0 million.

30

Management's Discussion and Analysis of Financial Condition and Results of Operations - Continued

During the six months ended June 30, 2021, the Company repaid $28.0 million under its Revolving Credit Facility, entered into an amended and restated credit facility in which the Company entered into a 7-year term loan facility totaling $125.0 million, repaid a $50.0 million term loan facility, and incurred $1.6 million in additional debt issuance costs. The Company also sold shares under its ATM Program and received proceeds of approximately $31.8 million, and paid dividends totaling approximately $20.8 million.

Security Deposits

As of June 30, 2022, the Company held approximately $5.3 million in security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon the security deposits if there are any defaults under the leases.

Dividends

The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to maintain its qualification as a REIT.

On July 28, 2022, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.4425 per share. The dividend is payable on August 26, 2022 to stockholders of record on August 12, 2022. This rate equates to an annualized dividend of $1.77 per share.

The ability of the Company to pay dividends is dependent upon its ability to generate cash flows and to make accretive new investments.

Corporate Responsibility

The Company is committed to conducting its business according to the highest ethical standards and upholding its corporate responsibilities as a public company operating for the benefit of its stockholders. The Company's Environmental, Social, and Governance (“ESG”) Committee charter is included on the Company’s website at www.chct.reit. Among other duties, the ESG Committee meets at least annually to review and recommend to the Board the general strategy and initiatives regarding ESG matters, including the Company’s internal and external communications and disclosures.

The Company’s Code of Ethics and Business Conduct not only applies to the Company's directors, officers, and other employees but also extends the Company's expectations that its vendors, service providers, contractors, and consultants will embrace the Company's commitment to integrity and personal responsibility by complying with this Code at all times. The Code of Ethics and Business Conduct includes the Company’s commitment to promote high standards of integrity by conducting its affairs honestly and ethically and to include in its periodic reports or other publicly available documents information and metrics related to internal monitoring, whistleblower, or reporting systems.

The Company’s whistleblower policy prohibits the Company and its affiliates and their officers, employees and agents from discharging, demoting, suspending, threatening, harassing or in any other manner discriminating against any employee for raising a concern. If an employee desires to raise a concern in a confidential or anonymous manner, the concern may be directed to the whistleblower officer at the Company’s whistleblower hotline. During the quarter ended June 30, 2022, the whistleblower officer received no whistleblower complaints.

The Company’s Information Technology infrastructure is cloud-based, utilizing Software as a Service (“SaaS”) applications for substantially all of its software requirements. The Company's IT Committee consists of the Chief Executive Officer, Chief Financial Officer, and the Vice President of Information Technology. The IT Committee reviews and discusses information security matters and cyber security risks. The committee meets at least twice a year and reports to the Board of Directors as needed or at least annually. The Company has adopted the Center of Internet Security (CIS) v8 IG1 cyber security controls including adopting an information security training program for its employees. Since the Company’s inception, the Company has not had a security breach resulting in expenses, penalties or settlements.

31

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We may use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We will not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors. An interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount. During the six months ended June 30, 2022, there were no material changes in the quantitative and qualitative disclosures about market risks presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

Changes In Internal Control Over Financial Reporting

There were no changes in our system of internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

The Company may, from time to time, be involved in litigation arising in the ordinary course of business or which may be expected to be covered by insurance. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 1A.    RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, an investor should consider the risk factors included in its Annual Report on Form 10-K for the year ended December 31, 2021 and other reports that may be filed by the Company.

ITEM 2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.   DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.   MINE SAFETY DISCLOSURES

None.

ITEM 5.   OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The exhibits required by Item 601 of Regulation S-K which are filed with this report are listed in the Exhibit Index and are hereby incorporated in by reference.

33

EXHIBIT INDEX

Exhibit No.	Description
3.1	Corporate Charter of Community Healthcare Trust Incorporated, as amended (1)
3.2	Amended and Restated Bylaws of Community Healthcare Trust Incorporated (2)
10.1 †	Second Amended and Restated Alignment of Interest Program (3)
31.1 *	Certification of the Chief Executive Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
31.2 *	Certification of the Chief Financial Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
32.1 **	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

___________________

(1)Filed as Exhibit 3.1 to Amendment No. 2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on May 6, 2015 (Registration No. 333-203210) and incorporated herein by reference.

(2)Filed as Exhibit 3.2 to the Quarterly Report on Form 10-Q of the Company filed with the Securities and Exchange Commission on November 3, 2020 (File No. 001-37401) and incorporated herein by reference.

(3)Filed as Exhibit 10.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on May 5, 2022 (File No. 001-37401) and incorporated herein by reference.

*    Filed herewith.

**    Furnished herewith.

†    Denotes executive compensation plan or arrangement.

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 2, 2022

COMMUNITY HEALTHCARE TRUST INCORPORATED
By:	/s/ Timothy G. Wallace
	Timothy G. Wallace
	Chief Executive Officer and President
By:	/s/ David H. Dupuy
	David H. Dupuy
	Executive Vice President and Chief Financial Officer

35

EX-31.1

Exhibit 31.1

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Timothy G. Wallace, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 2, 2022

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

EX-31.2

Exhibit 31.2

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David H. Dupuy, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 2, 2022

/s/ David H. Dupuy

David H. Dupuy

Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Community Healthcare Trust Incorporated

Certification Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated (the "Company") for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Wallace, Chief Executive Officer and President of the Company, and I, David H. Dupuy, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

i.The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

ii.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 2, 2022

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

/s/ David H. Dupuy

David H. Dupuy

Executive Vice President and Chief Financial Officer

XML

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Jul. 27, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-37401
Entity Registrant Name	Community Healthcare Trust Inc
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	46-5212033
Entity Address, Address Line One	3326 Aspen Grove Drive
Entity Address, Address Line Two	Suite 150
Entity Address, City or Town	Franklin
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37067
City Area Code	615
Local Phone Number	771-3052
Title of 12(b) Security	Common stock, $0.01 par value per share
Trading Symbol	CHCT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,099,256
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Real estate properties
Land and land improvements	$ 101,909	$ 97,397
Buildings, improvements, and lease intangibles	764,338	736,465
Personal property	234	223
Total real estate properties	866,481	834,085
Less accumulated depreciation	(149,049)	(133,056)
Total real estate properties, net	717,432	701,029
Cash and cash equivalents	1,699	2,351
Restricted cash	659	516
Other assets, net	66,244	50,337
Total assets	786,034	754,233
Liabilities
Debt, net	291,726	265,625
Accounts payable and accrued liabilities	7,219	7,845
Other liabilities, net	14,127	18,651
Total liabilities	313,072	292,121
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000 shares authorized; 25,099 and 24,983 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	251	250
Additional paid-in capital	599,631	595,624
Cumulative net income	70,231	59,123
Accumulated other comprehensive income (loss)	12,761	(4,980)
Cumulative dividends	(209,912)	(187,905)
Total stockholders’ equity	472,962	462,112
Total liabilities and stockholders' equity	$ 786,034	$ 754,233

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred Stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized (in shares)	450,000,000	450,000,000
Common Stock, shares issued (in shares)	25,099,000	24,983,000
Common Stock, shares outstanding (in shares)	25,099,000	24,983,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
REVENUES
Rental income	$ 23,197	$ 22,006	$ 45,801	$ 42,786
Other operating interest	852	682	1,729	1,297
Total revenue	24,049	22,688	47,530	44,083
EXPENSES
Property operating	4,062	3,843	8,153	7,572
General and administrative	3,610	2,893	6,926	5,752
Depreciation and amortization	8,077	7,539	16,019	14,763
Total expenses	15,749	14,275	31,098	28,087
INCOME BEFORE INCOME TAXES AND OTHER ITEMS	8,300	8,413	16,432	15,996
Interest expense	(2,755)	(2,736)	(5,381)	(4,966)
Deferred income tax (expense) benefit	(16)	(20)	1	(59)
Interest and other income	55	53	56	54
Net income	$ 5,584	$ 5,710	$ 11,108	$ 11,025
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.21	$ 0.22	$ 0.41	$ 0.43
Net income per common share – Diluted (in dollars per share)	$ 0.21	$ 0.22	$ 0.41	$ 0.43
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	23,578	23,195	23,574	23,003
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	23,578	23,195	23,574	23,003

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 5,584	$ 5,710	$ 11,108	$ 11,025
Other comprehensive income (loss):
Increase (decrease) in fair value of cash flow hedges	4,584	(2,788)	15,991	15
Reclassification for amounts recognized as interest expense	635	1,160	1,750	2,092
Total other comprehensive income (loss)	5,219	(1,628)	17,741	2,107
COMPREHENSIVE INCOME	$ 10,803	$ 4,082	$ 28,849	$ 13,132

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid in Capital	Cumulative Net Income	Accumulated Other Comprehensive Income (Loss)	Cumulative Dividends
Beginning balance (in shares) at Dec. 31, 2020		0	23,888
Beginning balance at Dec. 31, 2020	$ 429,916	$ 0	$ 239	$ 550,391	$ 36,631	$ (11,846)	$ (145,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)			683
Issuance of common stock, net of issuance costs	31,639		$ 7	31,632
Stock-based compensation (in shares)			116
Stock-based compensation	3,155		$ 1	3,154
Unrecognized gain on cash flow hedges	15					15
Reclassification adjustment for losses included in net income (interest expense)	2,092					2,092
Net income	11,025				11,025
Dividends to common stockholders	(20,786)						(20,786)
Ending balance (in shares) at Jun. 30, 2021		0	24,687
Ending balance at Jun. 30, 2021	457,056	$ 0	$ 247	585,177	47,656	(9,739)	(166,285)
Beginning balance (in shares) at Dec. 31, 2020		0	23,888
Beginning balance at Dec. 31, 2020	$ 429,916	$ 0	$ 239	550,391	36,631	(11,846)	(145,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	823
Ending balance (in shares) at Dec. 31, 2021		0	24,983
Ending balance at Dec. 31, 2021	$ 462,112	$ 0	$ 250	595,624	59,123	(4,980)	(187,905)
Beginning balance (in shares) at Mar. 31, 2021		0	24,417
Beginning balance at Mar. 31, 2021	450,086	$ 0	$ 244	571,781	41,946	(8,111)	(155,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)			248
Issuance of common stock, net of issuance costs	11,794		$ 2	11,792
Stock-based compensation (in shares)			22
Stock-based compensation	1,605		$ 1	1,604
Unrecognized gain on cash flow hedges	(2,788)					(2,788)
Reclassification adjustment for losses included in net income (interest expense)	1,160					1,160
Net income	5,710				5,710
Dividends to common stockholders	(10,511)						(10,511)
Ending balance (in shares) at Jun. 30, 2021		0	24,687
Ending balance at Jun. 30, 2021	457,056	$ 0	$ 247	585,177	47,656	(9,739)	(166,285)
Beginning balance (in shares) at Dec. 31, 2021		0	24,983
Beginning balance at Dec. 31, 2021	$ 462,112	$ 0	$ 250	595,624	59,123	(4,980)	(187,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	0
Issuance of common stock, net of issuance costs	$ (299)			(299)
Stock-based compensation (in shares)			116
Stock-based compensation	4,307		$ 1	4,306
Unrecognized gain on cash flow hedges	15,991					15,991
Reclassification adjustment for losses included in net income (interest expense)	1,750					1,750
Net income	11,108				11,108
Dividends to common stockholders	(22,007)						(22,007)
Ending balance (in shares) at Jun. 30, 2022		0	25,099
Ending balance at Jun. 30, 2022	472,962	$ 0	$ 251	599,631	70,231	12,761	(209,912)
Beginning balance (in shares) at Mar. 31, 2022		0	25,072
Beginning balance at Mar. 31, 2022	471,114	$ 0	$ 251	597,548	64,647	7,542	(198,874)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	(101)			(101)
Stock-based compensation (in shares)			27
Stock-based compensation	2,184		$ 0	2,184
Unrecognized gain on cash flow hedges	4,584					4,584
Reclassification adjustment for losses included in net income (interest expense)	635					635
Net income	5,584				5,584
Dividends to common stockholders	(11,038)						(11,038)
Ending balance (in shares) at Jun. 30, 2022		0	25,099
Ending balance at Jun. 30, 2022	$ 472,962	$ 0	$ 251	$ 599,631	$ 70,231	$ 12,761	$ (209,912)

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Cumulative Dividends
Dividends to common stockholders, per share (in dollars per share)	$ 0.44	$ 0.43	$ 0.8775	$ 0.8575

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
OPERATING ACTIVITIES
Net income	$ 11,108	$ 11,025
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	16,019	14,763
Other amortization	419	415
Stock-based compensation	4,307	3,155
Straight-line rent receivable	(1,737)	(1,818)
Deferred income tax (benefit) expense	(1)	59
Changes in operating assets and liabilities:
Other assets	(782)	(393)
Accounts payable and accrued liabilities	263	(108)
Other liabilities	(77)	1,004
Net cash provided by operating activities	29,519	28,102
INVESTING ACTIVITIES
Acquisitions of real estate	(28,671)	(68,921)
Acquisition and funding of notes receivable	(3,000)	(11,520)
Proceeds from the repayment of notes receivable	1,500	1,592
Capital expenditures on existing real estate properties	(3,648)	(3,065)
Net cash used in investing activities	(33,819)	(81,914)
FINANCING ACTIVITIES
Net borrowings (repayments) on revolving credit facility	26,000
Net borrowings (repayments) on revolving credit facility		(28,000)
Term loan borrowings	0	125,000
Term loan repayments	0	(50,000)
Mortgage note repayments	(69)	(57)
Dividends paid	(22,007)	(20,786)
Proceeds from issuance of common stock	0	31,793
Equity issuance costs	(133)	(130)
Debt issuance costs	0	(1,646)
Net cash provided by financing activities	3,791	56,174
(Decrease) increase in cash and cash equivalents and restricted cash	(509)	2,362
Cash and cash equivalents and restricted cash, beginning of period	2,867	2,892
Cash and cash equivalents and restricted cash, end of period	2,358	5,254
Supplemental Cash Flow Information:
Interest paid (net of capitalized interest)	5,053	4,599
Invoices accrued for construction, tenant improvement and other capitalized costs	1,395	1,240
Reclassification of registration statement costs incurred in prior year to equity issuance costs	221	163
Increase in fair value of cash flow hedges	15,991	15
Income taxes paid	42	25
Capitalized interest	$ 364	$ 73

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. As of June 30, 2022, the Company had investments of approximately $869.5 million in 159 real estate properties (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million). The properties are located in 34 states, totaling approximately 3.4 million square feet in the aggregate and were approximately 90.3% leased at June 30, 2022 with a weighted average remaining lease term of approximately 7.8 years. Any references to square footage, property count, or occupancy percentages, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm's review.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2022. All intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Cash and Cash Equivalents and Restricted Cash

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amounts approximate fair value due to the short term maturity of these investments. The following table provides a reconciliation of cash and cash equivalents and restricted cash:

	Balance as of June 30,
(Dollars in thousands)	2022		2021
Cash and cash equivalents	$	1,699	$	4,787
Restricted cash	659		467
Cash, cash equivalents and restricted cash	$	2,358	$	5,254

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and two subsidiaries have also elected for those subsidiaries to be treated as taxable REIT subsidiaries ("TRSs"), which are subject to federal and state income taxes.

No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRSs to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT.

New Accounting Pronouncements

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848). ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. During the first quarter of 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

XML

Real Estate Properties

6 Months Ended

Jun. 30, 2022

Real Estate [Abstract]

Real Estate Properties

REAL ESTATE PROPERTIES

As of June 30, 2022, we had investments of approximately $869.5 million in 159 real estate properties (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million). The Company's investments are diversified by property type, geographic location, and tenant as shown in the following tables:

Property Type	# of Properties	Gross Investment (in thousands)
Medical Office Building	65	$	298,680
Acute Inpatient Behavioral	5	130,410
Inpatient Rehabilitation Facilities	7	151,234
Specialty Centers	34	106,193
Physician Clinics	29	82,213
Surgical Centers and Hospitals	10	54,851
Behavioral Specialty Facilities	8	30,978
Long-term Acute Care Hospitals	1	14,937
Total	159	$	869,496

State	# of Properties	Gross Investment (in thousands)
Texas	15	$	137,523
Illinois	16	120,339
Ohio	23	101,144
Florida	14	66,265
Massachusetts	2	35,298
All Others	89	408,927
Total	159	$	869,496

Primary Tenant	# of Properties	Gross Investment (in thousands)
Everest Rehabilitation	4	$	80,658
US Healthvest	3	77,964
All Others	152	710,874
Total	159	$	869,496

XML

Real Estate Leases

6 Months Ended

Jun. 30, 2022

Leases [Abstract]

Real Estate Leases

REAL ESTATE LEASES

Lessor Accounting

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2039. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and may also include additional rent, which may include the reimbursement of taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property.

Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease.

Future minimum lease payments under the non-cancelable operating leases due to the Company for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ending December 31)	$	39,823
2023	76,469
2024	71,470
2025	66,222
2026	59,091
2027 and thereafter	375,290
	$	688,365

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis when collection of rental payments over the term of the lease is probable. Straight-line rent included in rental income was approximately $0.9 million and $1.0 million, respectively, for the three months ended June 30, 2022 and 2021, and was approximately $1.7 million and $1.8 million, respectively, for the six months ended June 30, 2022 and 2021.

Purchase Option Provisions

Certain of the Company's leases provide the lessee with a purchase option or a right of first refusal to purchase the leased property. The purchase option provisions generally allow the lessee to purchase the leased property at fair value or at an amount greater than the Company's gross investment in the leased property at the time of the purchase.

At June 30, 2022, the Company had an aggregate gross investment of approximately $28.1 million in five real estate properties with purchase options exercisable at June 30, 2022 that had not been exercised.

Sales-type Lease

The Company has a portion of one property accounted for as a sales-type lease with a gross amount totaling approximately $3.0 million included in other assets, net on the Company's Condensed Consolidated Balance Sheets. Future lease payments due to the Company under this lease for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ended December 31)	$	165
2023	336
2024	346
2025	356
2026	367
2027 and thereafter	5,587
Total undiscounted lease receivable	7,157
Discount	(4,124)
Lease receivable	$	3,033

The Company recognized interest income of approximately $0.1 million and $0.1 million, respectively, during the three months ended June 30, 2022 and 2021 and recognized approximately $0.2 million and $0.2 million, respectively, of interest income during the six months ended June 30, 2022 and 2021 related to this lease which is included in other operating interest on the Company's Consolidated Income Statements.

Lessee Accounting

At June 30, 2022, the Company was obligated, as the lessee, under four non-prepaid ground leases accounted for as operating leases with expiration dates, including renewal options, through 2076, and one non-prepaid ground lease accounted for as a financing lease with an expiration date through 2085, including renewal options. Any rental increases related to the Company's ground leases are generally either stated or based on the Consumer Price Index. The Company's future lease payments under these non-prepaid ground leases were as follows (in thousands):

	Operating		Financing
2022 (six months ended December 31)	$	21	$	63
2023	42		125
2024	43		138
2025	44		138
2026	44		138
2027 and thereafter	1,193		5,483
Total undiscounted lease payments	1,387		6,085
Discount	(596)		(3,114)
Lease liabilities	$	791	$	2,971

The following table discloses other information regarding the ground leases.

	June 30,
	2022		2021
Operating leases:
Weighted-average remaining lease term in years (including renewal options)	36.43		37.63
Weighted-average discount rate	4.0	%	4.0	%
Financing leases:
Weighted-average remaining lease term in years (including renewal options)	36.5		35.5
Weighted-average discount rate	4.1	%	4.1	%

XML

Real Estate Acquisitions

6 Months Ended

Jun. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Real Estate Acquisitions

REAL ESTATE ACQUISITIONS

During the second quarter of 2022, the Company acquired one real estate property. Upon acquisition, the property was 100% leased with a lease expiration in 2037. Amounts reflected in revenues and net income for this property for the three months ended June 30, 2022 were approximately $0.4 million and $0.3 million, respectively, and transaction costs totaling approximately $0.1 million were capitalized relating to the property acquisition.

During the first quarter of 2022, the Company acquired two real estate properties. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations through 2028. Amounts reflected in revenues and net income for these properties for the six months ended June 30, 2022 were approximately $0.3 million and $43,000, respectively, and transaction costs totaling approximately $0.1 million were capitalized relating to these property acquisitions.

Location	Property Type (1)	Date Acquired	Purchase Price		Cash Consideration		Real Estate		Other		Square Footage
			(000's)		(000's)		(000's)		(000's)
Toledo, OH	MOB	03/09/22	$	2,606	$	2,621	$	2,735	$	(114)	17,465
Fremont, NE	MOB	03/09/22	3,232		3,224		3,443		(219)		12,850
Cincinnati, OH	IRF	05/12/22	23,500		22,826		23,558		(732)		37,720
			$	29,338	$	28,671	$	29,736	$	(1,065)	68,035
(1) MOB - Medical Office Building; IRF - Inpatient Rehabilitation Facility

The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the six months ended June 30, 2022.

			Relative Fair Value		Estimated Useful Life
			(in thousands)		(in years)
Land and land improvements			$	4,258	12.7
Building and building improvements			24,290		45.3
Intangibles:
	At-market lease intangibles		1,187		4.5
	Below-market lease intangibles		(194)		6.1
		Total intangibles	993
Accounts payable, accrued liabilities and other liabilities assumed			(97)
Prorated rent, interest and operating expense reimbursement amounts collected			(773)
	Total cash consideration		$	28,671

XML

Debt, net

6 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Debt, net

DEBT, NET

The table below details the Company's debt as of June 30, 2022 and December 31, 2021.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021		Maturity Dates
Credit Facility:
Revolving Credit Facility	$	38,000	$	12,000	3/26
A-2 Term Loan, net	49,855		49,813		3/24
A-3 Term Loan, net	74,548		74,487		3/26
A-4 Term Loan, net	124,352		124,296		3/28
Mortgage Note Payable, net	4,971		5,029		5/24
	$	291,726	$	265,625

On March 19, 2021, Community Healthcare Trust Incorporated, as borrower, entered into a third amended and restated credit facility by and among Community Healthcare Trust Incorporated, as borrower, the several banks and financial institutions party thereto as lenders, and Truist Bank, as administrative agent (the "Credit Facility").

The Credit Facility allows the Company to borrow, through the accordion feature, up to $600.0 million, including the ability to add and fund incremental term loans, and provides the Company the ability to apply lower margins to its annual interest rate after it obtains an investment grade rating of BBB-/Baa3 (or the equivalent) from a rating agency, and modified its debt covenants.

The Credit Facility provides for a $150.0 million Revolving Credit Facility and $250.0 million in term loans (the "Term Loans"). The Revolving Credit Facility matures on March 19, 2026 and includes one 12-month option to extend the maturity date, subject to the satisfaction of certain conditions. The Term Loans include a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "A-2 Term Loan"), which matures on March 29, 2024, a seven-year term loan facility in the aggregate principal amount of $75.0 million (the "A-3 Term Loan"), which matures on March 29, 2026, and a seven-year term loan facility in the aggregate principal amount of $125.0 million (the "A-4 Term Loan), which matures on March 19, 2028.

Amounts outstanding under the Revolving Credit Facility bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 1.90% or (ii) a base rate plus 0.25% to 0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.20% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.25% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. The Company had $38.0 million outstanding under the Revolving Credit Facility with a weighted average interest rate of 2.9% and a borrowing capacity remaining of $112.0 million at June 30, 2022.

Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.45% to 2.30% or (ii) a base rate plus 0.45% to 1.30%, in each case, depending upon the Company’s leverage ratio. The Company has entered into interest rate swaps to fix the interest rates on the Term Loans. See Note 6 – Derivative Financial Instruments for more details on the interest rate swaps. At June 30, 2022, the Company had $250.0 million outstanding under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 3.79%.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. The Company was in compliance with its financial covenants under its Credit Facility as of June 30, 2022.

XML

Derivative Financial Instruments

6 Months Ended

Jun. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

DERIVATIVE FINANCIAL INSTRUMENTS

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

As of June 30, 2022, the Company had twelve outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $250.0 million.

Tabular Disclosure of Fair Value of Derivative Instruments on the Balance Sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
(Dollars in thousands)	June 30, 2022		December 31, 2021		Balance Sheet Classification	June 30, 2022		December 31, 2021		Balance Sheet Classification
Interest rate swaps	$	12,761	$	343	Other assets, net	$	—	$	5,324	Other liabilities, net

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) ("AOCI") and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $3.3 million will be reclassified from AOCI as a decrease to interest expense.

Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2022 and 2021.

	Three Months Ended June 30,				Six Months Ended June 30,
(Dollars in thousands)	2022		2021		2022		2021
Amount of unrealized gain (loss) recognized in OCI on derivatives	$	4,584	$	(2,788)	$	15,991	$	15
Amount of loss reclassified from AOCI into interest expense	$	635	$	1,160	$	1,750	$	2,092
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	2,755	$	2,736	$	5,381	$	4,966

Tabular Disclosures of Offsetting Derivatives

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of June 30, 2022 and December 31, 2021. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Condensed Consolidated Balance Sheets.

Offsetting of Derivative Assets (as of June 30, 2022)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	12,761	$	—	$	12,761	$	—	$	—	$	12,761

Offsetting of Derivative Liabilities (as of June 30, 2022)

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets

(In thousands)

Gross Amounts of Recognized Liabilities

Gross Amounts Offset in the Condensed Consolidated Balance Sheet

Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets

Financial Instruments

Cash Collateral Received

Net Amount

Derivatives

$

—

$

—

$

—

$

—

$

—

$

—

Offsetting of Derivative Assets (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	343	$	—	$	343	$	(247)	$	—	$	96

Offsetting of Derivative Liabilities (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	(5,324)	$	—	$	(5,324)	$	247	$	—	$	(5,077)

Credit-risk-related Contingent Features

As of June 30, 2022, the Company did not have any derivatives in a net liability position. As of June 30, 2022, the Company had not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company terminated these interest rate swaps or breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value.

XML

Stockholders' Equity

6 Months Ended

Jun. 30, 2022

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS' EQUITY

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2022 and for the year ended December 31, 2021:

(In thousands)	Six Months Ended June 30, 2022	Year Ended December 31, 2021
Balance, beginning of period	24,983	23,888
Issuance of common stock	—	823
Restricted stock issued	119	273
Restricted stock withheld and forfeited	(3)	(1)
Balance, end of period	25,099	24,983

ATM Program

The Company has an at-the-market offering program ("ATM Program"), with Piper Sandler & Co., Evercore Group L.L.C., Truist Securities, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC., as sales agents (collectively, the “Agents”). Under the ATM Program, the

Company may issue and sell shares of its common stock, having an aggregate gross sales price of up to $360.0 million. The shares of common stock may be sold from time to time through or to one or more of the Agents, as may be determined by the Company in its sole discretion, subject to the terms and conditions of the agreement and applicable law.

The Company elected not to issue any shares under the ATM Program during the six months ended June 30, 2022. As of June 30, 2022, the Company had approximately $101.0 million remaining that may be issued under the ATM Program.

XML

Net Income Per Common Share

6 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Net Income Per Common Share

NET INCOME PER COMMON SHARE

The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2022 and 2021, respectively.

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except per share data)	2022		2021		2022		2021
Net income	$	5,584	$	5,710	$	11,108	$	11,025
Participating securities' share in earnings	(668)		(547)		(1,327)		(1,085)
Net income, less participating securities' share in earnings	$	4,916	$	5,163	$	9,781	$	9,940
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	25,087		24,457		25,074		24,256
Unvested restricted shares	(1,509)		(1,262)		(1,500)		(1,253)
Weighted average Common Shares outstanding–Basic	23,578		23,195		23,574		23,003
Dilutive potential common shares	—		—		—		—
Weighted average Common Shares outstanding –Diluted	23,578		23,195		23,574		23,003
Basic Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43
Diluted Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43

XML

Stock Incentive Plan

6 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement [Abstract]

Stock Incentive Plan

STOCK INCENTIVE PLAN

A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three and six months ended June 30, 2022 and 2021 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods.

		Three Months Ended June 30,				Six Months Ended June 30,
(Dollars and shares in thousands)		2022		2021		2022		2021
Stock-based awards, beginning of period		1,502		1,258		1,416		1,165
	Stock in lieu of compensation	8		6		52		50
	Stock awards	19		16		67		65
	Total stock granted	27		22		119		115
	Vested shares	(17)		(20)		(22)		(20)
	Forfeited shares	—		—		(1)		—
Stock-based awards, end of period		1,512		1,260		1,512		1,260
Amortization expense		$	2,184	$	1,606	$	4,307	$	3,164

XML

Other Assets, net

6 Months Ended

Jun. 30, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets, net

OTHER ASSETS, NET

Other assets, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Notes receivable	$	27,500	$	26,000
Accounts and interest receivable	2,463		2,116
Straight-line rent receivable	13,723		11,968
Prepaid assets	728		701
Deferred financing costs, net	790		896
Leasing commissions, net	1,389		1,239
Deferred tax assets, net	349		348
Fair value of interest rate swaps	12,761		343
Above-market lease intangible assets, net	517		611
Sales-type lease receivable	3,033		3,031
Financing right-of-use asset	1,844		1,870
Operating lease right-of-use assets	774		788
Other	373		426
	$	66,244	$	50,337

The Company's notes receivable mainly included:

•At June 30, 2022 and December 31, 2021, notes receivable included a $10.5 million and $12.0 million, respectively, term loan, secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital owned by the borrower. The term loan will be repaid in equal monthly installments of $250,000 through the maturity date of December 31, 2025 and bears interest at 9% per annum.

•At June 30, 2022 and December 31, 2021, notes receivable included a $6.0 million and $6.0 million, respectively, term loan and a $11.0 million and $8.0 million, respectively, revolving credit facility, secured by assets and ownership interests of six geriatric behavioral hospitals and affiliated companies all of which are co-borrowers on the loans. The term loan bears interest at 9% per annum, with interest only payments due initially and then equal monthly installments of principal payments due beginning June 30, 2023. The term loan facility matures on July 1, 2027. The revolving credit facility bears interest at 9% per annum and matures on December 31, 2025. In addition, the Company has committed to fund, at the Company’s discretion, additional amounts, up to $5.0 million with interest at 9% per annum on any amount funded, that may be used by the borrower to pay existing liabilities of co-borrowers. The term loan, the revolving credit facility and the additional commitment all include a 3% non-cash interest charge that is due and payable upon the earlier of the repayment or maturity of each note.

The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material decision-making rights or control of the entities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at June 30, 2022 are summarized in the table below.

Classification	Carrying Amount (in thousands)		Maximum Exposure to Loss (in thousands)
Note receivable (term loan)	$	10,500	$	10,500
Note receivable (revolving credit facility)	$	11,000	$	11,000
Note receivable (term loan)	$	6,000	$	6,000

XML

Other Liabilities, net

6 Months Ended

Jun. 30, 2022

Other Liabilities Disclosure [Abstract]

Other Liabilities, net

OTHER LIABILITIES, NET

Other liabilities, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Prepaid rent	$	3,967	$	3,791
Security deposits	5,224		4,640
Below-market lease intangibles, net	720		616
Fair value of derivatives	—		5,324
Financing lease liability	2,971		2,973
Operating lease liability	791		795
Other	454		512
	$	14,127	$	18,651

XML

Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

FAIR VALUE OF FINANCIAL INSTRUMENTS

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy.

Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy.

The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at June 30, 2022 and December 31, 2021, using level 2 inputs.

	June 30, 2022				December 31, 2021
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Notes receivable	$	27,500	$	26,641	$	26,000	$	25,869
Interest rate swap asset	$	12,761	$	12,761	$	343	$	343
Interest rate swap liability	$	—	$	—	$	5,324	$	5,324
Mortgage note payable (principal amount)	$	5,007	$	4,886	$	5,076	$	5,129

XML

Subsequent Events

6 Months Ended

Jun. 30, 2022

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

Dividend Declared

On July 28, 2022, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.4425 per share. The dividend is payable on August 26, 2022 to stockholders of record on August 12, 2022.

Restricted Stock Issuances

On July 29, 2022, the Company issued 72,431 shares of restricted stock to its executive officers under the Company's 2014 Incentive Plan with an 8-year vesting period.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2022. All intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents and Restricted CashCash and cash equivalents includes short-term investments with original maturities of three months or less when purchased.

Restricted Cash

Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amounts approximate fair value due to the short term maturity of these investments.

Income Taxes

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and two subsidiaries have also elected for those subsidiaries to be treated as taxable REIT subsidiaries ("TRSs"), which are subject to federal and state income taxes.

No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRSs to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT.

New Accounting Pronouncements

New Accounting Pronouncements

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848). ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. During the first quarter of 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Restrictions on cash and cash equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash:

	Balance as of June 30,
(Dollars in thousands)	2022		2021
Cash and cash equivalents	$	1,699	$	4,787
Restricted cash	659		467
Cash, cash equivalents and restricted cash	$	2,358	$	5,254

Schedule of cash and cash equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash:

	Balance as of June 30,
(Dollars in thousands)	2022		2021
Cash and cash equivalents	$	1,699	$	4,787
Restricted cash	659		467
Cash, cash equivalents and restricted cash	$	2,358	$	5,254

XML

Real Estate Properties (Tables)

6 Months Ended

Jun. 30, 2022

Real Estate [Abstract]

Schedule of real estate property investments

The Company's investments are diversified by property type, geographic location, and tenant as shown in the following tables:

Property Type	# of Properties	Gross Investment (in thousands)
Medical Office Building	65	$	298,680
Acute Inpatient Behavioral	5	130,410
Inpatient Rehabilitation Facilities	7	151,234
Specialty Centers	34	106,193
Physician Clinics	29	82,213
Surgical Centers and Hospitals	10	54,851
Behavioral Specialty Facilities	8	30,978
Long-term Acute Care Hospitals	1	14,937
Total	159	$	869,496

State	# of Properties	Gross Investment (in thousands)
Texas	15	$	137,523
Illinois	16	120,339
Ohio	23	101,144
Florida	14	66,265
Massachusetts	2	35,298
All Others	89	408,927
Total	159	$	869,496

Primary Tenant	# of Properties	Gross Investment (in thousands)
Everest Rehabilitation	4	$	80,658
US Healthvest	3	77,964
All Others	152	710,874
Total	159	$	869,496

XML

Real Estate Leases (Tables)

6 Months Ended

Jun. 30, 2022

Leases [Abstract]

Schedule of future minimum lease payments for operating leases

Future minimum lease payments under the non-cancelable operating leases due to the Company for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ending December 31)	$	39,823
2023	76,469
2024	71,470
2025	66,222
2026	59,091
2027 and thereafter	375,290
	$	688,365

Sales-type maturity

Future lease payments due to the Company under this lease for the years ending December 31, as of June 30, 2022, are as follows (in thousands):

2022 (six months ended December 31)	$	165
2023	336
2024	346
2025	356
2026	367
2027 and thereafter	5,587
Total undiscounted lease receivable	7,157
Discount	(4,124)
Lease receivable	$	3,033

Schedule of operating lease payments

The Company's future lease payments under these non-prepaid ground leases were as follows (in thousands):

	Operating		Financing
2022 (six months ended December 31)	$	21	$	63
2023	42		125
2024	43		138
2025	44		138
2026	44		138
2027 and thereafter	1,193		5,483
Total undiscounted lease payments	1,387		6,085
Discount	(596)		(3,114)
Lease liabilities	$	791	$	2,971

Schedule of finance lease payments

The Company's future lease payments under these non-prepaid ground leases were as follows (in thousands):

	Operating		Financing
2022 (six months ended December 31)	$	21	$	63
2023	42		125
2024	43		138
2025	44		138
2026	44		138
2027 and thereafter	1,193		5,483
Total undiscounted lease payments	1,387		6,085
Discount	(596)		(3,114)
Lease liabilities	$	791	$	2,971

Ground leases

The following table discloses other information regarding the ground leases.

	June 30,
	2022		2021
Operating leases:
Weighted-average remaining lease term in years (including renewal options)	36.43		37.63
Weighted-average discount rate	4.0	%	4.0	%
Financing leases:
Weighted-average remaining lease term in years (including renewal options)	36.5		35.5
Weighted-average discount rate	4.1	%	4.1	%

XML

Real Estate Acquisitions (Tables)

6 Months Ended

Jun. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of acquisitions

Location	Property Type (1)	Date Acquired	Purchase Price		Cash Consideration		Real Estate		Other		Square Footage
			(000's)		(000's)		(000's)		(000's)
Toledo, OH	MOB	03/09/22	$	2,606	$	2,621	$	2,735	$	(114)	17,465
Fremont, NE	MOB	03/09/22	3,232		3,224		3,443		(219)		12,850
Cincinnati, OH	IRF	05/12/22	23,500		22,826		23,558		(732)		37,720
			$	29,338	$	28,671	$	29,736	$	(1,065)	68,035
(1) MOB - Medical Office Building; IRF - Inpatient Rehabilitation Facility

Schedule of assets acquired and liabilities assumed

The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the six months ended June 30, 2022.

			Relative Fair Value		Estimated Useful Life
			(in thousands)		(in years)
Land and land improvements			$	4,258	12.7
Building and building improvements			24,290		45.3
Intangibles:
	At-market lease intangibles		1,187		4.5
	Below-market lease intangibles		(194)		6.1
		Total intangibles	993
Accounts payable, accrued liabilities and other liabilities assumed			(97)
Prorated rent, interest and operating expense reimbursement amounts collected			(773)
	Total cash consideration		$	28,671

XML

Debt, net (Tables)

6 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Schedule of debt

The table below details the Company's debt as of June 30, 2022 and December 31, 2021.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021		Maturity Dates
Credit Facility:
Revolving Credit Facility	$	38,000	$	12,000	3/26
A-2 Term Loan, net	49,855		49,813		3/24
A-3 Term Loan, net	74,548		74,487		3/26
A-4 Term Loan, net	124,352		124,296		3/28
Mortgage Note Payable, net	4,971		5,029		5/24
	$	291,726	$	265,625

XML

Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair value of derivative instruments on balance sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
(Dollars in thousands)	June 30, 2022		December 31, 2021		Balance Sheet Classification	June 30, 2022		December 31, 2021		Balance Sheet Classification
Interest rate swaps	$	12,761	$	343	Other assets, net	$	—	$	5,324	Other liabilities, net

The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Condensed Consolidated Balance Sheets.

Offsetting of Derivative Assets (as of June 30, 2022)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	12,761	$	—	$	12,761	$	—	$	—	$	12,761

Offsetting of Derivative Liabilities (as of June 30, 2022)

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets

(In thousands)

Gross Amounts of Recognized Liabilities

Gross Amounts Offset in the Condensed Consolidated Balance Sheet

Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets

Financial Instruments

Cash Collateral Received

Net Amount

Derivatives

$

—

$

—

$

—

$

—

$

—

$

—

Offsetting of Derivative Assets (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	343	$	—	$	343	$	(247)	$	—	$	96

Offsetting of Derivative Liabilities (as of December 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(In thousands)	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	(5,324)	$	—	$	(5,324)	$	247	$	—	$	(5,077)

Schedule of derivative gain (loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2022 and 2021.

	Three Months Ended June 30,				Six Months Ended June 30,
(Dollars in thousands)	2022		2021		2022		2021
Amount of unrealized gain (loss) recognized in OCI on derivatives	$	4,584	$	(2,788)	$	15,991	$	15
Amount of loss reclassified from AOCI into interest expense	$	635	$	1,160	$	1,750	$	2,092
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	2,755	$	2,736	$	5,381	$	4,966

XML

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2022

Equity [Abstract]

Schedule of reconciliation of common stock

The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2022 and for the year ended December 31, 2021:

(In thousands)	Six Months Ended June 30, 2022	Year Ended December 31, 2021
Balance, beginning of period	24,983	23,888
Issuance of common stock	—	823
Restricted stock issued	119	273
Restricted stock withheld and forfeited	(3)	(1)
Balance, end of period	25,099	24,983

XML

Net Income Per Common Share (Tables)

6 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Schedule of earnings per share

The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2022 and 2021, respectively.

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except per share data)	2022		2021		2022		2021
Net income	$	5,584	$	5,710	$	11,108	$	11,025
Participating securities' share in earnings	(668)		(547)		(1,327)		(1,085)
Net income, less participating securities' share in earnings	$	4,916	$	5,163	$	9,781	$	9,940
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	25,087		24,457		25,074		24,256
Unvested restricted shares	(1,509)		(1,262)		(1,500)		(1,253)
Weighted average Common Shares outstanding–Basic	23,578		23,195		23,574		23,003
Dilutive potential common shares	—		—		—		—
Weighted average Common Shares outstanding –Diluted	23,578		23,195		23,574		23,003
Basic Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43
Diluted Net Income per Common Share	$	0.21	$	0.22	$	0.41	$	0.43

XML

Stock Incentive Plan (Tables)

6 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement [Abstract]

Summary of nonvested restricted stock activity

A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three and six months ended June 30, 2022 and 2021 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods.

		Three Months Ended June 30,				Six Months Ended June 30,
(Dollars and shares in thousands)		2022		2021		2022		2021
Stock-based awards, beginning of period		1,502		1,258		1,416		1,165
	Stock in lieu of compensation	8		6		52		50
	Stock awards	19		16		67		65
	Total stock granted	27		22		119		115
	Vested shares	(17)		(20)		(22)		(20)
	Forfeited shares	—		—		(1)		—
Stock-based awards, end of period		1,512		1,260		1,512		1,260
Amortization expense		$	2,184	$	1,606	$	4,307	$	3,164

XML

Other Assets, net (Tables)

6 Months Ended

Jun. 30, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of other assets

Other assets, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Notes receivable	$	27,500	$	26,000
Accounts and interest receivable	2,463		2,116
Straight-line rent receivable	13,723		11,968
Prepaid assets	728		701
Deferred financing costs, net	790		896
Leasing commissions, net	1,389		1,239
Deferred tax assets, net	349		348
Fair value of interest rate swaps	12,761		343
Above-market lease intangible assets, net	517		611
Sales-type lease receivable	3,033		3,031
Financing right-of-use asset	1,844		1,870
Operating lease right-of-use assets	774		788
Other	373		426
	$	66,244	$	50,337

Schedule of VIEs

The VIEs that we have identified at June 30, 2022 are summarized in the table below.

Classification	Carrying Amount (in thousands)		Maximum Exposure to Loss (in thousands)
Note receivable (term loan)	$	10,500	$	10,500
Note receivable (revolving credit facility)	$	11,000	$	11,000
Note receivable (term loan)	$	6,000	$	6,000

XML

Other Liabilities, net (Tables)

6 Months Ended

Jun. 30, 2022

Other Liabilities Disclosure [Abstract]

Schedule of other liabilities

Other liabilities, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 are detailed in the table below.

	Balance as of
(Dollars in thousands)	June 30, 2022		December 31, 2021
Prepaid rent	$	3,967	$	3,791
Security deposits	5,224		4,640
Below-market lease intangibles, net	720		616
Fair value of derivatives	—		5,324
Financing lease liability	2,971		2,973
Operating lease liability	791		795
Other	454		512
	$	14,127	$	18,651

XML

Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value, by balance sheet grouping

The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at June 30, 2022 and December 31, 2021, using level 2 inputs.

	June 30, 2022				December 31, 2021
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Notes receivable	$	27,500	$	26,641	$	26,000	$	25,869
Interest rate swap asset	$	12,761	$	12,761	$	343	$	343
Interest rate swap liability	$	—	$	—	$	5,324	$	5,324
Mortgage note payable (principal amount)	$	5,007	$	4,886	$	5,076	$	5,129

XML

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands, ft² in Millions	Jun. 30, 2022 USD ($) ft² real_estate_property state	Dec. 31, 2021 USD ($)
Accounting Policies [Abstract]
Total real estate properties | $	$ 869,496
Number of real estate properties | real_estate_property	159
Number of properties held for investment in financing lease | real_estate_property	1
Financing lease liability | $	$ 2,971	$ 2,973
Number of states | state	34
Area of real estate property (in square feet) | ft²	3.4
Percentage leased	90.30%
Remaining lease term	7 years 9 months 18 days

XML

Summary of Significant Accounting Policies - Cash and Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Cash and cash equivalents	$ 1,699	$ 2,351	$ 4,787
Restricted cash	659	516	467
Cash, cash equivalents and restricted cash	$ 2,358	$ 2,867	$ 5,254	$ 2,892

XML

Real Estate Properties - Additional Information (Details) $ in Thousands	Jun. 30, 2022 USD ($) real_estate_property	Dec. 31, 2021 USD ($)
Real Estate [Abstract]
Total real estate properties | $	$ 869,496
Number of real estate properties | real_estate_property	159
Number of properties held for investment in financing lease | real_estate_property	1
Financing lease liability | $	$ 2,971	$ 2,973

XML

Real Estate Properties - Schedule of Real Estate Property Investments (Details) $ in Thousands	Jun. 30, 2022 USD ($) real_estate_property
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	159
Total real estate properties | $	$ 869,496
Everest Rehabilitation
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	4
Total real estate properties | $	$ 80,658
US Healthvest
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	3
Total real estate properties | $	$ 77,964
All Others
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	152
Total real estate properties | $	$ 710,874
Texas
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	15
Total real estate properties | $	$ 137,523
Illinois
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	16
Total real estate properties | $	$ 120,339
Ohio
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	23
Total real estate properties | $	$ 101,144
Florida
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	14
Total real estate properties | $	$ 66,265
Massachusetts
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	2
Total real estate properties | $	$ 35,298
All Others
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	89
Total real estate properties | $	$ 408,927
Medical Office Building
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	65
Total real estate properties | $	$ 298,680
Acute Inpatient Behavioral
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	5
Total real estate properties | $	$ 130,410
Inpatient Rehabilitation Facilities
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	7
Total real estate properties | $	$ 151,234
Specialty Centers
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	34
Total real estate properties | $	$ 106,193
Physician Clinics
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	29
Total real estate properties | $	$ 82,213
Surgical Centers and Hospitals
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	10
Total real estate properties | $	$ 54,851
Behavioral Specialty Facilities
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	8
Total real estate properties | $	$ 30,978
Long-term Acute Care Hospitals
Real Estate Properties [Line Items]
Number of real estate properties | real_estate_property	1
Total real estate properties | $	$ 14,937

XML

Real Estate Leases - Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Leases [Abstract]
2022 (six months ending December 31)	$ 39,823
2023	76,469
2024	71,470
2025	66,222
2026	59,091
2027 and thereafter	375,290
Total	$ 688,365

XML

Real Estate Leases - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) real_estate_property lease	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) real_estate_property lease	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Concentration Risk [Line Items]
Straight line rent	$ 900	$ 1,000	$ 1,737	$ 1,818
Real estate investment property, net	$ 717,432		$ 717,432		$ 701,029
Number of real estate properties | real_estate_property	159		159
Lease receivable	$ 3,033		$ 3,033		$ 3,031
Number of properties held for investment in financing lease | real_estate_property	1		1
Interest income	$ 100	$ 100	$ 200	$ 200
Number of operating leases | lease	4		4
Number of finance leases | lease	1		1
Four Real Estate Property
Concentration Risk [Line Items]
Real estate investment property, net	$ 28,100		$ 28,100
Number of real estate properties | real_estate_property	5		5

XML

Real Estate Leases - Lease Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Leases [Abstract]
2022 (six months ended December 31)	$ 165
2023	336
2024	346
2025	356
2026	367
2027 and thereafter	5,587
Total undiscounted lease receivable	7,157
Discount	(4,124)
Lease receivable	$ 3,033	$ 3,031

XML

Real Estate Leases - Future Lease Payments Under Non-prepaid Ground Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Operating
2022 (six months ended December 31)	$ 21
2023	42
2024	43
2025	44
2026	44
2027 and thereafter	1,193
Total undiscounted lease payments	1,387
Discount	(596)
Lease liabilities	791	$ 795
Financing
2022 (six months ended December 31)	63
2023	125
2024	138
2025	138
2026	138
2027 and thereafter	5,483
Total undiscounted lease payments	6,085
Discount	(3,114)
Lease liabilities	$ 2,971	$ 2,973

XML

Real Estate Leases - Ground Leases (Details)	Jun. 30, 2022	Jun. 30, 2021
Operating leases:
Weighted-average remaining lease term in years (including renewal options)	36 years 5 months 4 days	37 years 7 months 17 days
Weighted-average discount rate	4.00%	4.00%
Financing leases:
Weighted-average remaining lease term in years (including renewal options)	36 years 6 months	35 years 6 months
Weighted-average discount rate	4.10%	4.10%

XML

Real Estate Acquisitions - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) real_estate_property	Mar. 31, 2022 real_estate_property	Jun. 30, 2022 USD ($)
Business Acquisition [Line Items]
Number of real estate properties acquired | real_estate_property	1	2
Acquisitions Of Properties During Q2 2022
Business Acquisition [Line Items]
Percentage of properties that were leased at acquisition	100.00%
Pro forma information, revenue of acquiree since acquisition date, actual	$ 400
Pro forma information, income of acquiree since acquisition date, actual	300
Transaction costs	$ 100
Acquisitions Of Properties During Q1 2022
Business Acquisition [Line Items]
Percentage of properties that were leased at acquisition		100.00%
Pro forma information, revenue of acquiree since acquisition date, actual			$ 300
Pro forma information, income of acquiree since acquisition date, actual			43
Transaction costs			$ 100

XML

Real Estate Acquisitions - Real Estate Acquisitions (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($) ft²
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Square footage (in square feet) | ft²	3,400,000
Acquisitions Of Properties During Q1 2022 | Toledo, OH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,606
Cash Consideration	2,621
Real Estate	2,735
Other	$ (114)
Square footage (in square feet) | ft²	17,465
Acquisitions Of Properties During Q1 2022 | Fremont, NE
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 3,232
Cash Consideration	3,224
Real Estate	3,443
Other	$ (219)
Square footage (in square feet) | ft²	12,850
Acquisitions Of Properties During Q2 2022 | Cincinnati, OH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 23,500
Cash Consideration	22,826
Real Estate	23,558
Other	$ (732)
Square footage (in square feet) | ft²	37,720
Series of Individually Immaterial Asset Acquisitions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 29,338
Cash Consideration	28,671
Real Estate	29,736
Other	$ (1,065)
Square footage (in square feet) | ft²	68,035

XML

Real Estate Acquisitions - Assets Acquired and Liabilities Assumed (Details) - Series of Individually Immaterial Asset Acquisitions $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Business Acquisition [Line Items]
Land and land improvements	$ 4,258
Building and building improvements	24,290
Intangibles:
Below-market lease intangibles	$ (194)
Below market lease useful life (in years)	6 years 1 month 6 days
Total intangibles	$ 993
Accounts payable, accrued liabilities and other liabilities assumed	(97)
Prorated rent, interest and operating expense reimbursement amounts collected	(773)
Total cash consideration	28,671
At-market lease intangibles
Intangibles:
Lease intangibles	$ 1,187
Intangibles useful life (in years)	4 years 6 months
Land and land improvements
Business Acquisition [Line Items]
Estimated useful life (in years)	12 years 8 months 12 days
Building and building improvements
Business Acquisition [Line Items]
Estimated useful life (in years)	45 years 3 months 18 days

XML

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Debt, net	$ 291,726	$ 265,625
Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	250,000
Mortgage Note Payable, net
Debt Instrument [Line Items]
Debt, net	4,971	5,029
Revolving Credit Facility | Line of Credit | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	38,000	12,000
A-2 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	49,855	49,813
A-3 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	74,548	74,487
A-4 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	$ 124,352	$ 124,296

XML

Debt, net - Narrative (Details)	Mar. 19, 2021 USD ($) option	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Line of Credit Facility [Line Items]
Amount outstanding		$ 291,726,000	$ 265,625,000
Third Amended And Restated Credit Facility | Term Loan
Line of Credit Facility [Line Items]
Amount outstanding		$ 250,000,000
Weighted average interest rate percentage		3.79%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.45%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	2.30%
Third Amended And Restated Credit Facility | Base Rate | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	0.45%
Third Amended And Restated Credit Facility | Base Rate | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.30%
Third Amended And Restated Credit Facility | Credit Facility, Accordion Feature
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 600,000,000
Third Amended And Restated Credit Facility | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000
Number of options to extend | option	1
Length of extension	12 months
Amount outstanding		$ 38,000,000	12,000,000
Weighted average interest rate percentage		2.90%
Remaining borrowing capacity		$ 112,000,000
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.90%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.90%
Third Amended And Restated Credit Facility | Term Loan | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 250,000,000
Third Amended And Restated Credit Facility | A-2 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Debt term	7 years
Face amount	$ 50,000,000
Amount outstanding		49,855,000	49,813,000
Third Amended And Restated Credit Facility | A-3 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Debt term	7 years
Face amount	$ 75,000,000
Amount outstanding		74,548,000	74,487,000
Third Amended And Restated Credit Facility | A-4 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Debt term	7 years
Face amount	$ 125,000,000
Amount outstanding		$ 124,352,000	$ 124,296,000
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.20%
Percentage of borrowing capacity outstanding	33.30%
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.25%
Percentage of borrowing capacity outstanding	33.30%

XML

Derivative Financial Instruments - Narrative (Details)	6 Months Ended
	Jun. 30, 2022 USD ($) derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 3,300,000
Cash Flow Hedging | Interest Rate Contract
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	12
Notional amount	$ 250,000,000

XML

Derivative Financial Instruments - Fair Value Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Interest rate swap asset	$ 12,761	$ 343
Interest rate swap liability	0	5,324
Cash Flow Hedging | Interest rate swaps | Designated as Hedging Instrument | Other assets, net
Derivatives, Fair Value [Line Items]
Interest rate swap asset	12,761	343
Cash Flow Hedging | Interest rate swaps | Designated as Hedging Instrument | Other liabilities, net
Derivatives, Fair Value [Line Items]
Interest rate swap liability	$ 0	$ 5,324

XML

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract - Cash Flow Hedging - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized gain (loss) recognized in OCI on derivatives	$ 4,584	$ (2,788)	$ 15,991	$ 15
Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of loss reclassified from AOCI into interest expense	635	1,160	1,750	2,092
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 2,755	$ 2,736	$ 5,381	$ 4,966

XML

Derivative Financial Instruments - Offsetting of Derivative Assets and Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Derivative Asset [Abstract]
Gross Amounts of Recognized Assets	$ 12,761	$ 343
Gross Amounts Offset in the Condensed Consolidated Balance Sheet	0	0
Net Amounts of Assets in the Condensed Consolidated Balance Sheets	12,761	343
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	0	(247)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Net Amount	0	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral Received	12,761	96
Derivative Liability [Abstract]
Gross Amounts of Recognized Liabilities	0	(5,324)
Gross Amounts Offset in the Condensed Consolidated Balance Sheet	0	0
Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets	0	(5,324)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments	0	247
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral Received	0	0
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Net Amount	$ 0	$ (5,077)

XML

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares shares in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	24,983	23,888
Issuance of common stock (in shares)	0	823
Restricted stock issued (in shares)	119	273
Restricted stock withheld and forfeited (in shares)	(3)	(1)
Balance, end of period (in shares)	25,099	24,983

XML

Stockholders' Equity - Additional Information (Details) - At The Market Offering Program - Common Stock shares in Millions, $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) shares
Subsidiary, Sale of Stock [Line Items]
Value of shares authorized | $	$ 360.0
Shares available for issuance (in shares) | shares	101.0

XML

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Earnings Per Share [Abstract]
Net income	$ 5,584	$ 5,710	$ 11,108	$ 11,025
Participating securities' share in earnings	(668)	(547)	(1,327)	(1,085)
Net income, less participating securities' share in earnings	$ 4,916	$ 5,163	$ 9,781	$ 9,940
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	25,087	24,457	25,074	24,256
Unvested restricted shares (in shares)	(1,509)	(1,262)	(1,500)	(1,253)
Weighted average Common Shares outstanding–Basic (in shares)	23,578	23,195	23,574	23,003
Dilutive potential common share (in shares)	0	0	0	0
Weighted average Common Shares outstanding –Diluted (in shares)	23,578	23,195	23,574	23,003
Basic Net Income per Common Share (in dollars per share)	$ 0.21	$ 0.22	$ 0.41	$ 0.43
Diluted Net Income per Common Share (in dollars per share)	$ 0.21	$ 0.22	$ 0.41	$ 0.43

XML

Stock Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Restricted Common Stock
Stock-based awards:
Stock-based awards, beginning of period (in shares)	1,502	1,258	1,416	1,165
Granted (in shares)	27	22	119	115
Vested (in shares)	(17)	(20)	(22)	(20)
Forfeited (in shares)	0	0	(1)	0
Stock-based awards, end of period (in shares)	1,512	1,260	1,512	1,260
Amortization expense	$ 2,184	$ 1,606	$ 4,307	$ 3,164
Stock in lieu of compensation
Stock-based awards:
Granted (in shares)	8	6	52	50
Stock awards
Stock-based awards:
Granted (in shares)	19	16	67	65

XML

Other Assets, net - Other Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 27,500	$ 26,000
Accounts and interest receivable	2,463	2,116
Straight-line rent receivable	13,723	11,968
Prepaid assets	728	701
Deferred financing costs, net	790	896
Leasing commissions, net	1,389	1,239
Deferred tax assets, net	349	348
Fair value of interest rate swaps	12,761	343
Above-market lease intangible assets, net	517	611
Sales-type lease receivable	3,033	3,031
Financing right-of-use asset	1,844	1,870
Operating lease right-of-use assets	774	788
Other	373	426
Other assets, net	$ 66,244	$ 50,337

XML

Other Assets, net - Narrative (Details)	6 Months Ended
	Jun. 30, 2022 USD ($) hospital	Dec. 31, 2021 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 27,500,000	$ 26,000,000
Note receivable (term loan) | Variable Interest Entity, Not Primary Beneficiary
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 10,500,000
Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate	9.00%
Additional funding	$ 5,000,000
Non-cash interest rate	3.00%
Note receivable (term loan) | Variable Interest Entity, Not Primary Beneficiary
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 6,000,000	6,000,000
Note receivable (revolving credit facility) | Variable Interest Entity, Not Primary Beneficiary
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 11,000,000	8,000,000
Geriatric Behavioral Hospital
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	6
Revolving Credit Facility | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate	9.00%
Note receivable (term loan) | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 10,500,000	$ 12,000,000
Payment received	$ 250,000
Note receivable interest rate	9.00%
Note receivable (term loan) | Long-Term Acute Care Hospitals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Note receivable (term loan) | Inpatient Rehabilitation Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1

XML

Other Assets, net - VIEs (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Carrying amount	$ 27,500	$ 26,000
Variable Interest Entity, Not Primary Beneficiary | Note receivable (term loan)
Variable Interest Entity [Line Items]
Carrying amount	10,500
Maximum exposure to loss	10,500
Variable Interest Entity, Not Primary Beneficiary | Note receivable (revolving credit facility)
Variable Interest Entity [Line Items]
Carrying amount	11,000	8,000
Maximum exposure to loss	11,000
Variable Interest Entity, Not Primary Beneficiary | Note receivable (term loan)
Variable Interest Entity [Line Items]
Carrying amount	6,000	$ 6,000
Maximum exposure to loss	$ 6,000

XML

Other Liabilities, net (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
Prepaid rent	$ 3,967	$ 3,791
Security deposits	5,224	4,640
Below-market lease intangibles, net	720	616
Fair value of derivatives	0	5,324
Financing lease liability	2,971	2,973
Operating lease liability	791	795
Other	454	512
Other liabilities, net	$ 14,127	$ 18,651

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	$ 27,500	$ 26,000
Interest rate swap asset	12,761	343
Interest rate swap liability	0	5,324
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	27,500	26,000
Mortgage note payable (principal amount)	5,007	5,076
Carrying Value | Interest rate swap liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	12,761	343
Interest rate swap liability	0	5,324
Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	26,641	25,869
Mortgage note payable (principal amount)	4,886	5,129
Fair Value | Interest rate swap liability | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	12,761	343
Interest rate swap liability	$ 0	$ 5,324

XML

Subsequent Events (Details) - Subsequent Event - $ / shares	Jul. 29, 2022	Jul. 28, 2022
Subsequent Event [Line Items]
Dividend declared (in dollars per share)		$ 0.4425
Restricted Common Stock | Executive Officer
Subsequent Event [Line Items]
Restricted common stock granted (in shares)	72,431
Vesting period	8 years